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ABSTRACT 
 
 
The objective of this thesis was to investigate and expand the use of testis tissue 
xenografting as means of maintaining the developmental potential of donor testis tissue.  
The objective of the first study was to investigate the effect of donor age on 
spermatogenesis in canine testis tissue after xenografting into immunodeficient recipient 
mice. Fragments of testis tissue from 12 dogs of different ages were xenografted under the 
back skin of mice. Donors were categorized based on testis developmental status at the 
time of grafting into: less than four months (immature), four to six months (young), and 
greater than six months of age (adult). The grafts were evaluated at four, six or eight 
months post-grafting. At four months post-grafting, immature and young groups had 
higher graft recovery rates (92 ± 5.8 and 88 ± 4.4% versus 69 ± 3.5%; P = 0.001 and P = 
0.001), graft weights (34 ± 8.1 and 32 ± 11.0 mg versus 7 ± 2.6 mg; P = 0.001 and P = 
0.02), vesicular gland indices (1.1 ± 0.20 and 0.6 ± 0.18% versus 0.1 ± 0.03%; P < 0.0001 
and  P = 0.02), seminiferous tubule numbers (517 ± 114.8 and 364 ± 161.0 versus 10 ± 
5.1; P < 0.0001 and P = 0.03), and larger seminiferous tubular diameters (140 ± 17.8 and 
130 ± 3.4 µm versus 55 ± 21.9 µm; P = 0.003 and P = 0.001), compared to adult donor 
xenografts. Xenografts from immature donors maintained the growth and development for 
eight months, as exhibited by greater graft weights (17 ± 4.6 mg, P = 0.002), seminiferous 
tubule numbers (547 ± 210.3, P < 0.01) and tubular diameters (93 ± 15.9 µm, P < 0.0001), 
and induced greater vesicular gland indices (1.5 ± 0.46%, P = 0.0005), compared to adult 
donor xenografts.  The growth and development of testis tissue xenografts from immature 
and young donors were not different after eight months (P > 0.05). Young donor 
xenografts had greater seminiferous tubule number and diameter compared to adult donor 
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xenografts (P = 0.009 and P = 0.004, respectively) at eight months post-grafting. 
Elongated spermatids were the most advanced germ cell type present at four and eight 
months post-grafting in the testis grafts of immature and young age groups.  
The objective of the second study was to evaluate three different strategies to 
preserve/cryopreserve immature porcine testis tissue. Immature porcine testes were cooled 
at 4 °C for 24, 48 or 72 hours, and testis tissue fragments were cryopreserved using 
programmed slow freezing with dimethyl sulfoxide (DMSO), glycerol, or ethylene glycol, 
or vitrified using DMSO or glycerol at 5, 15 or 30 min exposure time. In vitro cell 
viability was determined by trypan blue exclusion, and in vivo developmental potential 
was evaluated by xenografting into immunodeficient mice. Compared to fresh tissue, 
short-term cooling of porcine testis tissue resulted in similar in vitro cell survival rates (93 
± 2.2% for fresh versus 95 ± 0.3, 93 ± 1.7 and 87 ± 4.3%  after 24, 48 and 72 hours at 4 
°C, respectively; P = 0.74) and in vivo development, with generation of elongated 
spermatids and sperm after four months of grafting. Cryopreservation of testis tissue with 
programmed slow freezing using glycerol and vitrification with DMSO (5 min 
equilibration) or glycerol (5 or 15 min equilibration) did not compromise the 
developmental competence of xenografts when compared to fresh tissue (control), 
characterized by the formation of elongated spermatids and sperm.  
These findings suggest that canine testis tissue from immature donors and cooling of 
immature porcine testis tissue to refrigerator temperature for up to 72 hours or 
cryopreservation with slow controlled freezing or vitrification could be suitable methods 
to restore male fertility following xenografting. 
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CHAPTER 1: GENERAL INTRODUCTION 
Production of sperm is a very organized process that generates virtually unlimited 
numbers of gametes during adulthood. This continuous proliferation and differentiation of 
germ cells requires a delicate balance of function among all testis compartments [1]. Many 
complex aspects of testis function remain elusive due to the lack of suitable in vitro or in 
vivo models.  
Cross-species transplantation of heterogeneous populations of testis cells, including 
spermatogonial stem cells, recovered from donor rats or hamsters into recipient mice 
testis, has resulted in the establishment of rat or hamster spermatogenesis in the mouse 
testis [2, 3]. This has not been the case with the transplantation of spermatogonial germ 
cells from phylogenetically more distant species into mouse testes, and did not result in 
spermatogenesis beyond spermatogonial proliferation. The failure of spermatogenesis is 
likely a result of the incompatibility of microenvironments [4, 5]. This has led to the recent 
development of an alternative approach, namely testis tissue xenografting. Xenografting 
involves the grafting of testis tissue from a wide range of immature donors under the back 
skin of immunodeficient recipient mice. This has successfully resulted in the 
establishment of spermatogenesis [6-13]. Sperm collected from such grafts are 
fertilization-competent, support the development of embryos [6, 8, 12], and lead to the 
birth of offspring using the tissues of neonatal donor animals [14]. 
Preservation of genetic material is crucial for conservation of rare animal breeds or lines. 
The loss of genetic diversity associated with infertility or premature death of valuable 
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species is also a major ongoing problem in wild life conservation. Current attempts to 
address this problem through assisted reproduction involve the collection of sperm or ova 
from the valuable animals, before or after death. These attempts have several limitations. 
The most important concern relates to the collection of sperm from males that die before 
reaching sexual maturity. The use of fresh or cryopreserved immature donor testis tissue in 
xenografting could circumvent such limitations. This novel approach can also be used to 
study spermatogenesis. The accessibility of grafted tissue located along the back in the 
recipient mouse makes it possible to manipulate spermatogenesis and steroidogenesis in a 
controlled manner. This may not be easy or feasible in the donor animal. This, in turn, 
would allow the analysis of the effects of new hormone regimens, drugs, or toxicants on 
testis function of a target species via xenografting in a laboratory mouse. 
There has been a wide range of species that have been used as donors for testis tissue 
xenografting [6-11], but there are no reports of studies using dogs as donor animals. 
Development of canine testis tissue xenografting methodology could improve the 
investigation and manipulation of testis function in this species. It could also offer the 
possibility of preserving genetic potential of canids undergoing castration before 
maturation. Testis tissue xenografting may prove to be a valuable tool in the conservation 
of the threatened or endangered canine species that die prematurely. This could further aid 
in the conservation and maintenance of the existing biodiversity in wild life. Many studies 
indicate the benefits of xenografting in the establishment of spermatogenesis of the 
neonatal and prepubertal testes in immunodeficient recipient mice [6-12].  
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The first objective of this study was to investigate the effect of donor age on 
spermatogenesis in canine testis tissue after xenografting into immunodeficient recipient 
mice. As part of our attempt to expand the application of testis tissue xenografting, the 
second objective was to determine the enhanced preservation conditions of immature 
porcine testis tissue, as a model, to maintain the testis developmental potential. Short-term 
preservation would mimic shipment on ice, whereas long-term preservation would reflect 
the storage of the testis tissue for months or years. Difficulties finding donors of the same 
age-range or breed for replicate experiments made it unfeasible to consider dog testis 
tissue for cryopreservation. Therefore, it was decided to use immature porcine testis tissue 
to study the effects of cryoprotectants, equilibration times and freezing rates on the 
survival of testis tissue. 
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CHAPTER 2: LITERATURE REVIEW  
 I. TESTIS TISSUE XENOGRAFTING 
Recently, considerable research has been dedicated to finding practical techniques for 
male germ line conservation, manipulation and propagation. As the scope and significance 
of biodiversity loss have become more apparent, positive actions such as xenografting 
must be examined in order to deal with the crisis, especially in rare and endangered 
species. This novel method may also, in the future, provide an important contribution to 
the treatment of human infertility caused by genetic defects or cytotoxic therapies.  
Xenografting of testis tissue under the back skin of recipient immunodeficient mice has 
provided a tool for the study and manipulation of the male germ line [6]. Completion of 
spermatogenesis in neonatal or immature testis tissue xenografts, from diverse species, 
establishes the appropriateness of this in vivo model. The immunocompromised nude 
mouse serves as an in vivo incubator which provides a suitable environment for the growth 
and development of the donor-derived testis tissue grafts. 
This procedure has allowed the development of spermatogenesis in testis tissue xenografts 
obtained from several species including immature: mice, hamsters, rabbits, cattle, horses, 
pigs, goats, cats, monkeys, and sheep in immunodeficient recipient mice [6-15]. Complete 
spermatogenesis including sperm production from immature donor mice, hamsters, cats, 
rabbits, pigs, goats, cattle or rhesus monkeys was successfully produced using the 
xenografting technique [6-10, 16]. Fertility competence of sperm derived from testis tissue 
xenografts has been verified by the generation of blastocysts in the pig and monkey and 
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also offspring in the mouse and rabbit using intracytoplasmic sperm injection (ICSI) [8, 
12, 16]. Xenografting of testis tissue, therefore, may pave the way for the restoration of the 
male germ line and fertility preservation. It has been suggested that testis tissue 
xenografting and using the resultant xenogeneic sperm could be an alternative option for 
recovered cancer patients to circumvent the risk of re-introduction of neoplastic cells by 
methods such as auto-transplantation of isolated germ cells [17].  
 In large animals and humans, the study and manipulation of spermatogenesis and 
steroidogenesis is challenging and costly. Consequently, xenografting into a laboratory 
rodent model would facilitate this challenge [18, 19]. Spermatogenesis requires optimal 
conditions for successful sperm production, where the slightest changes in testis 
environment such as temperature variation might disrupt the process. Therefore, using a 
proper in vivo model is much more desirable than the corresponding in vitro model in 
controlled studies to produce optimal results. This approach, although in the experimental 
stage, could provide new avenues for clinical intervention in assisted reproductive 
technologies, where alternative techniques are not available or applicable.  
Several issues need to be addressed in order to effectively improve testis tissue 
xenografting in different species. This manuscript attempts to provide a general review of 
past and current efforts for xenografting of testis tissue, prospective implications, and 
future clinical applications. The critical “what’s next” question in xenografting of the 
testis tissue impinges on controversial issues related to preservation of human fertility. 
There are both technical and ethical issues concerning the acquisition of human testis 
biopsy, re-establishment, preservation and restoration of testis tissue. 
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2.1 Key concepts of testis tissue xenografting 
2.1.1 Immunodeficient mouse: a suitable ‘in vivo’ lab model  
The availability of proper in vitro and in vivo models is critical to provide a well-balanced 
environment for spermatogonial cell differentiation and self-renewal. The study of testis 
tissue development using an in vivo model, without working directly on the target species, 
could be cost-effective and may help address some of the ethical issues limiting the 
maintenance and treatment of large animals or non-human primate species [8]. The NCr 
nude (nu/nu) and severely combined immunodeficient (SCID) mice have been used as 
mouse models for grafting and transplantation studies [6, 17, 20]. The immune response is 
altered in these mice to circumvent foreign tissue rejection. The autosomal recessive nude 
gene in homozygous (nu/nu) mice prevents the growth of hair, and development of normal 
thymus [21]. The compromised T-lymphocyte function allows athymic mice to accept and 
grow grafted tissues. SCID mice are homozygous for the severe combined 
immunodeficiency mutation which leads to a blockage in both B- and T-lymphocyte 
development [22]. Shortage of natural killer cells, macrophages and complement activity 
has also been suggested as contributing factors in the prevention of foreign tissue rejection 
in immunodeficient mice [23]. No significant difference has been reported between nude 
and SCID mice concerning the re-establishment, growth, and development of 
spermatogenic cells in xenografts [10, 17].  
Recipient mice are usually castrated at the time of grafting in order to remove the source 
of testosterone, leading to a dramatic rise in gonadotrophins, and thereby providing a 
stimulus for the newly grafted tissues. In other words, the pathway of the hypothalamus-
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pituitary-gonadal feedback loop in the recipient mice switches to the hypothalamus-
pituitary of the recipient mouse and Leydig cells of the xenograft [6]. Lowered levels of 
serum LH in the grafted recipient mice demonstrate that Leydig cells in the grafted tissues 
are able to produce sufficient testosterone to provide the negative feedback on 
gonadotrophin production [6]. In castrated mice, in the absence of androgens, vesicular 
glands regress to about 10% of their normal size in intact mice. Therefore, measuring the 
weight of the vesicular glands can be used as an indicator of the levels of biologically-
active testosterone in castrated recipient mice [6]. 
2.1.2 Ideal grafting site 
Spermatogenesis in mammals usually takes place at a temperature that is a few degrees 
below that of the normal body core temperature. Therefore, the site of grafting into the 
recipient mouse is critical for growth and development of the ectopically grafted testis 
tissue. In general, the ideal site should provide an environment for the grafts that is 
comparable to the in situ condition, in terms of both blood supply and temperature. 
Possible sites for transplantation of the testis tissue that have been examined include the 
intraocular region [24], the skin of the thoracic area [24], the scrotum [18, 25], beneath the 
kidney capsule [19], under the skin of the outer ear [18, 26], and the axillary area [25]. 
Complete spermatogenesis was reported in the scrotum and under the skin of outer ear of 
rats [18]; whereas the anterior chamber of the eye and thoracic skin allowed only for the 
recovery of the grafted tissues [24]. Exposure to different temperatures is an obvious, and 
perhaps the most important difference among these regions, which might influence the late 
stages of spermatogenesis [26]. Grafting of immature testis tissue under the back skin, 
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between the shoulders and rump of recipient mice, has achieved spermatogenesis from 
different mammalian donor species [6-8, 10, 14]. The area under the dorsal skin appears to 
be a superior environment for the ectopically grafted testis tissues. The lack of hair in the 
recipient mice has been suggested as an additional factor contributing to the lowered 
temperature under the back skin which enhances spermatogenesis [27]. In most mammals, 
normal spermatogenesis occurs in an environment 4-6 °C cooler than body temperature 
[28]. Spermatogenesis arrest in cryptorchid testes affirms the impact of temperature, 
which halts the formation of round and elongating spermatids [29]. In one study, however,  
using a limited number of nude and SCID mice with complete fur, no difference in the 
degree of spermatogenesis was observed [10]. The lower core body temperature in the 
mouse (about 36-37 °C), compared to usually higher temperatures for most other species, 
may explain the suitability of the mouse model.  
Vascularization is likely another key factor for the successful development of grafted 
tissues. Most grafted tissues show minor initial damages which might be related to an 
episode of hypoxic ischemia shortly after implantation [11]. Intraocular [24], 
intramuscular  [24], and sub-capsular kidney grafting sites [19] have been proven to be 
suitable vascular beds for testis tissue transplants. However, these sites might not provide 
adequate physical features, nor an appropriate temperature for tissue growth. In addition, it 
has been suggested that immature grafts more readily undergo angiogenesis and resist 
post-grafting ischemia better than the mature testis tissue [7]. Tissue damages related to 
hypoxia during grafting appears to be more detrimental for differentiated germ cells than 
for the earlier stages [11]. This may explain the lower success rates with tissue from 
mature donors as compared to tissues from immature donors [30]. 
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2.1.3 Spermatogenesis follow-up  
Spermatogenesis is a regular, cyclic proliferation and differentiation of germ cells 
resulting in production of virtually unlimited numbers of sperm during the life of a male. 
Germ cells of different types must have closely coordinated interplay with Sertoli cells to 
be able to undergo mitosis, meiosis, and differentiation [31]. Spermatogonial stem cell 
(SSC) renewal is also believed to be highly dependent on Sertoli cell support to guarantee 
the continual production of sperm during adulthood [32]. Leydig and Sertoli cells produce 
testosterone and estrogen, which are necessary to maintain the hormonal milieu of testis 
tissue through the hypothalamus-pituitary-testis feedback mechanism [31]. 
Spermatogonial stem cells are enclosed in seminiferous cords and tubules and form the 
foundation of spermatogenesis. They periodically undergo self-renewal and give rise to 
differentiating daughter cells. These stem cells are mostly characterized as “Asingle” (As), 
which account for the generation of proliferative spermatogonia (Aaligned or Aal, Apaired or 
Apr). Aal are also thought to be a part of the self-renewal pool of spermatogonia [31].  
Asingle cells may be transplanted into the seminiferous tubules of recipient testes and are 
capable of colonization [33]. This could offer novel applications in the production of 
transgenic animals via transduction of desired genetic materials into spermatogonia before 
transplantation. Different visual reporter genes such as GFP and LacZ have been added to 
monitor spermatogenic activities [5]. These approaches could further address the study 
and manipulation of spermatogenesis using this model. 
During the seminiferous epithelium differentiation, As cells give rise to a controlled cyclic 
generation of A1 to A2, A3, A4, intermediate, and B spermatogonia. B spermatogonia enter 
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in meiosis to generate preleptotene and leptotene cells. Morphological changes of nuclear 
chromatin provide a basis of spermatogenic cell classification. Zygotene and pachytene 
cells, in which chromosome pairing occurs, then advance through the second meiosis with 
the generation of spermatids [31]. 
The cellular kinetics of pre-meiotic, meiotic, and post-meiotic phases in the testis tissue 
are extremely organized. Testis tissue xenografting can provide conditions that are 
sufficiently identical to those of the donor testes to allow the continuation or the re-
establishment of spermatogenesis [4, 34]. Analysis of ectopically grafted testis tissues 
usually includes histological evaluation of the recovered graft, spermatogonial 
proliferation, and progression through spermatogenesis [8]. Formation of a tubular lumen 
within seminiferous cords indicates maturation of Sertoli cells with complete regulatory 
and nursing capacity to support the progression of spermatogenesis [6, 35]. It appears that 
only SSCs have the potential to induce or restore spermatogenesis after transplantation 
into recipient mouse testes [36]. Low numbers of SSCs in the adult mouse testis and 
identical morphology to their immediate daughter progeny cells make it quite challenging 
to distinguish and to isolate SSCs [36, 37]. Xenografting of testis tissue might provide a 
powerful tool for in vivo confirmation of the ability of SSCs in a specific tissue sample to 
undergo spermatogenesis. 
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2.1.4 Endocrine and paracrine support of grafted tissues 
In castrated animals, the absence of testosterone and its suppressive effects on 
gonadotrophins cause the levels of gonadotrophins to increase to higher than normal 
values. After xenografting of testis tissue into castrated immunodeficient recipient mice, 
Leydig cells in the newly grafted testis tissue begin to produce testosterone in response to 
LH and eventually re-establish the cyclic negative feedback on LH [6]. Gonadotrophins 
affect testis growth, steroidogenesis and gametogenesis [38]. Despite the generally 
perceived species-specificity of gonadotrophins, these observations collectively indicate 
that the ectopically grafted testis tissues from a wide range of donor species are 
steroidogenically active in the recipient mouse and responsive, to a large degree, to mouse 
gonadotrophin stimulation. Nevertheless, low efficiency of testis tissue xenografting for 
certain donor species such as the bovine and equine species, may be attributed to the lack 
of compatibility between the donor-derived testosterone and recipient mouse 
gonadotrophins [11]. 
Internal gene expression and surrounding environment of SSCs are responsible for 
stability of the cellular interactions in the testis tissue [39]. Although the function of SSCs 
is critical for spermatogenesis, little is known about the essential factors controlling their 
activity. Glial cell line-derived neurotrophic factor (GDNF) is a secretory protein of 
Sertoli cells acting as one of the critical factors facilitating SSC-Sertoli cell 
communication [39]. The first report describing the important role of GDNF on SSC 
function in vivo was based on observations characterizing reduced spermatogonial 
proliferation in adult heterozygous mice testes [40]. The explanation for the reduced 
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spermatogonial proliferation in adults was over-expression of GDNF in testis [40].  On the 
other hand, excessive GDNF has been shown to induce SSC proliferation and self-renewal 
during the perinatal period [1]. 
Sertoli cell transcription factor ERM (Ets-related molecule) is reported to be essential for 
SSC self-renewal after puberty [1]. It has been demonstrated that other factors such as 
basic fibroblast growth factor (bFGF), insulin-like growth factor (IGF), leukemia 
inhibitory factor (LIF), and epidermal growth factor (EGF) may support the proliferation 
of spermatogonia in vitro and in vivo [39, 41, 42]. Finding critical species-specific factors 
and cellular pathways may assist the establishment of spermatogenesis in species which 
have not exhibited successful testis tissue xenografting, such as marmosets, horses, and 
bulls.  
2.1.5 General procedures for ectopic grafting of testis tissue 
Following collection of the donor tissue through castration of neonatal or immature donors 
and removal of the tunica albuginea, small fragments of dissected donor testes are 
arbitrarily assigned to be used for ectopic testis grafting in different recipient mice. Some 
are fixed for use as a reference for histology. Usually eight fragments of donor testis 
tissues are grafted under the back skin of castrated immunodeficient mice (SCID or NCr 
nude). Different donor species vary in the time to testis maturation. Therefore, the time of 
graft retrieval for analysis varies depending on the progression of spermatogenic cells in 
the intact testis tissue in situ. The histological examination of xenografts includes the 
assessment of general morphological changes in the tissue and the diameter of 
seminiferous tubules. Differentiation status and characterization of the most advanced 
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germ cells are recorded to estimate developmental progress. In addition to the evaluation 
of xenograft development, serum levels of testosterone and the gonadotrophins can be 
determined in blood. The relative weight of the vesicular glands is highly androgen-
dependent and reflects the bioactivity of testosterone produced by the xenografts [6, 8, 11, 
15, 43].  
In situations where the sperm can be retrieved by mechanical dispersion of the testis 
grafts, fertility competence of the sperm can be determined by intracytoplasmic sperm 
injection (ICSI) into the cytoplasm of metaphase II oocytes [8]. Verification of embryo 
parentage has been used to further confirm that the blastocysts formed are indeed due to 
fertilization and not due to parthenogenesis [8].  
2.2 Grafting of testis tissue from different donor species 
Spermatogenesis has been extensively studied only in some species, but xenografting 
can provide an ex situ assessment of testis development and spermatogenesis from a 
variety of donor species in an in vivo rodent model. Since testis tissue from different 
donor species behaves differently following ectopic grafting into mice, it is necessary to 
briefly review the development from each donor species to determine the role of the 
donor on testis tissue growth and developmental progression. 
2.2.1 Testis tissue xenografting in laboratory and companion animals 
2.2.1.1 Allografting of murine testis tissue 
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Allografting (grafts sourced from a genetically non-identical member of the same species) 
of newborn mouse testis tissue into nude mice lead to completely functional donor-derived 
spermatogenesis four weeks after grafting. Regardless of the mixed recovery rate of the 
seminiferous tubules in the grafted tissue, the kinetics of spermatogenesis were similar to 
those of the intact testis [6, 7, 14]. Grafting of newborn mouse testis tissue is a valuable 
technique to evaluate the potential of spermatogonia for spermatogonial stem cell 
proliferation, and seminiferous tubular development. Testosterone levels of the castrated 
recipients of testis allografts were comparable to those of intact mice indicating that the 
androgen concentration is normalized after allografting immature mouse testis tissue [7]. It 
should be noted that the overall mass of the grafted testis tissue in the recipient mice was 
greater than total mass of two testes in an intact mouse [14]. Accumulation of excessive 
fluid causing expansion of the luminal part of seminiferous tubules may cause pressure 
necrosis of the seminiferous epithelium after two months. This major drawback was 
ironically seen only when mouse testis tissue was allografted in mice [6, 14]. Seminiferous 
tubule dilation was also observed following surgical obstruction of efferent ducts, and in 
the estrogen receptor knockout mice which may endure defects or lack of efferent ducts 
[44, 45]. Therefore, tubular dilation of the allografts appears to be the result of a non-
functional duct system to drain the tubular fluid. This was confirmed by allografting an 
intact neonatal mouse testis along with its epididymis which resulted in the development 
of morphologically normal tubules in the grafted tissue [14]. The testis allografts re-
establish a strong androgenic negative feedback on gonadotrophin release from the 
recipient mice. Furthermore, compartmental damage in testis allografts did not inhibit the 
capability of interstitial leydig cells to produce testosterone or to interrupt the feedback 
mechanisms [14]. Since this damage does not affect the function of Leydig cells and the 
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androgen levels, testis tissue grafting in mice can provide an excellent strategy to assess 
androgen production or its biological mechanisms in the testis tissue [14]. The ICSI of the 
graft-derived sperm into oocytes, and consequent embryo transfer to a surrogate mother 
gave rise to the birth of fertile male and female mouse pups [14]. Therefore, allografting of 
the testis tissue can be used to investigate testis developmental potential and 
spermatogenic function of testes from neonatally lethal mutants [46].  
Spermatogenesis in adult testis allografts was not comparable to that of immature 
allografts. Allografts of an adult donor mouse into recipient mice produce qualitatively 
inferior degrees of spermatogenesis, severe atrophy, and tissue degeneration. This may be 
associated with the fact that very few stem cells re-establish spermatogenesis in allografts 
of adult donors [7]. The resultant donor-derived sperm in the allografts of adult donors 
might have originated from germ cells which completed differentiation after grafting [7]. 
In all probability, there is a greater chance of survival of immature testis tissue after a 
period of ischemia following grafting procedures compared to that of adult testis tissue. It 
is also thought that there is more effective vascularization in immature testis tissue 
allografts compared to than that of adult donor testis tissues [7].  
2.2.1.2 Xenografting of rat and hamster testis tissue 
The initiation, development, and maintenance of spermatogenesis in testis tissue 
xenografts from newborn rats followed a pattern similar to that of immature mouse grafts, 
from both quantity- and quality perspectives. A high ratio of meiotic to post-meiotic germ 
cells followed by completion of spermatogenesis was reported from newborn rat testis 
tissue xenografts. The classic cellular morphology and hormonal function of Leydig cells 
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were seen in the xenografts. In contrast, when the photoperiod-regressed adult hamster 
testes, which were used to mimic a prepubertal state, were grafted into mice, the grafts 
showed extreme degeneration and inefficiently recovered Leydig cells. This was probably 
associated with the inability of the tissue to stimulate angiogenesis, and subsequent 
ischemia [7, 47].  
Gassei et al. (2006) developed a new model of xenografting using in vitro-generated cell 
aggregates
 
derived from dissociated immature rat testis tissue [48]. They suggested that 
the composition of immature testis cell has the potential to initiate Sertoli cell
 
aggregation 
in vitro and proceed further to in vivo development and differentiation of germinal cells 
after grafting [48]. 
2.2.1.3 Xenografting of feline testis tissue  
Feline testis tissue xenografts have shown gradual progression in growth and 
development. Kitten testis tissues were capable of initiating spermatogenesis after 
xenografting into immunocompromised mice; however, quantitatively few sperm could be 
retrieved from these xenografts. The time frame of testis maturation was reported to be 
similar to that of intact cats, indicating that mouse-derived gonadotrophins and xenograft-
gonadotrophin interplay were effective. Increased weight of the vesicular glands indicated 
the release of bioactive androgens from the xenografts [10]. However, these authors could 
not carry out a complete investigation, due to the premature death of a number of recipient 
mice infected with an unrelated viral infection [10]. In another study, sperm were 
successfully obtained from xenografts of immature donor cats aged 8 to 16 weeks [49]. 
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Xenografts from mature donors more than 8 months of age showed complete degeneration 
[49].  
The efficiency of sperm production in feline xenografts and the possibility of testis tissue 
xenografting from endangered feline species are yet to be determined. Nevertheless, the 
initial outcome of feline testis tissue xenografting is encouraging, especially for future 
research on germ line preservation of endangered feline species. Additionally, feline testis 
tissue xenografting might provide an accessible in vivo model which would facilitate the 
study and manipulation of spermatogenesis and the prevention of diversity loss in feral 
feline species. 
2.2.2 Testis tissue xenografting in farm animals  
2.2.2.1 Xenografting of equine testis tissue  
Xenografting of equine testis tissue into recipient mice resulted in spermatogenesis up to 
the meiosis stages. Presence of pachytene spermatocytes, as the most advanced germ cells 
in xenografts at four months period, confirmed the meiotic arrest [11]. The underlying 
reasons for grafting inefficiency to develop post-meiotic stages are not completely clear. It 
has been suggested that the development of xenografts in horses is highly age-dependent. 
Testis xenografts from very immature donor horses (about 2 weeks old) were not able to 
begin differentiation and showed a very low survival rate. Xenografts from peripubertal 
equine testes (i.e. 10 and 12 months old horses) had a higher survival rate and displayed 
limited developmental progress beyond the pachytene stage over the first four months of 
grafting. The limited efficiency of xenografts from peripubertal testes might be due to 
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degeneration of existing differentiated germ cells and impaired differentiation of 
remaining SSCs.  Sexually mature donor testis tissue xenografts (4 year old horses) 
showed severe degeneration of seminiferous tubules which was likely associated with the 
low tolerance to ischemia shortly after grafting [11, 30].  
Levels of serum testosterone in recipient mice were low, suggesting the insufficient 
endogenous gonadotrophin release or inadequate bioactivity of murine gonadotrophins on 
equine Leydig cells [11].  Administration of exogenous gonadotrophins into recipient mice 
enhanced germ cell differentiation by formation of elongated spermatids in some 
xenografts, compared to untreated recipient mice, but had no effect on the percentage of 
seminiferous tubules with differentiated germ cells or the weight of the vesicular glands 
[11]. Elimination of these possible deficiencies might improve the performance of equine 
xenografts. Using donors of the same breed, specific ranges of donor age, and time 
adjustment of exogenous gonadotrophin therapies might reduce the variability of the 
responses and elucidate the observed inefficiencies in the reported data by Rathi et al 
(2006) [11]. Equine testis tissue xenografting could provide an option for fertility 
preservation of valuable and rare horse breeds, where other techniques of fertility 
preservation and restoration are not feasible. 
2.2.2.2 Xenografting of bovine testis tissue  
Testis tissue xenografts from prepubertal donor bull calves yielded good recovery rates 
with complete cellular differentiation. Regardless of the age of the pre-pubertal bull 
donors, spermatogenesis proceeded to produce elongated spermatids. In older donors, the 
progression of spermatogenesis declined over time [15, 43, 50]. Therefore, the age of the 
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donor and the time period allowed for the grafts to mature in recipient mice, are critical 
factors for the development ofspermtogenesis development in bovine testis tissue 
xenografting [43, 51]. The timing of post-grafting spermatogenesis has proved 
controversial. While spermatogenesis in testis tissue xenografts was reported to be 
equivalent to that of the testis in situ condition [9], accelerated spermatogenesis was 
demonstrated in another study by the same group [43]. In general, substantial acceleration 
of lumen formation, accelerated pre-meiotic phases of spermatogenesis, and generation of 
pachytene spermatocytes, as well as, low efficiency of post-meiotic differentiation have 
been reported as the major characteristics of bovine testis tissue xenografting by Rathi et 
al. [15]. In addition, as suggested by Huang et al. (2008), early onset of spermatogenesis 
was observed in xenografts that mainly contained undifferentiated germ cells at the time 
of grafting; whereas, the presence of more advanced germ cells in the donor tissue resulted 
in poor graft development [50]. 
Evidently, the excessively low efficiency of spermatogenesis (≤ 10%) and germ cell loss 
in xenografts are challenging aspects of bull calf testis tissue xenografting [9, 15, 43]. 
Moreover, low initial numbers of germ cells in xenografts might be due to an ineffective 
re-population or primary pre-meiotic arrest of these germ cells in xenografts. Seminiferous 
tubule dilation related to fluid accumulation also occurs in bovine xenografts [15], 
although with a much lower incidence than reported for mouse testis tissue xenografts [6]. 
In contrast to primate testis tissue xenografts [8], Huang et al. (2008) observed no 
differences in the development in bovine testis tissue xenografts between castrated and 
non-castrated recipient mice [50].  
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Improvements in the methods of xenografting, such as the stimulation of vascularization 
and endocrine / paracrine support of early differentiating spermatogonial cells, may 
contribute to the spermatogenesis efficiency [50]. Schmidt et al. (2006),
 
for the first time,
 
indicated that exposure of bovine testis tissue, prior to grafting, to vascular endothelial 
growth factor (VEGF) assists spermatogonial stem cell growth, proliferation and 
differentiation [52]. It has been suggested that discovery of the gene expression patterns 
during different phases of angiogenesis and growth of xenografts might provide a new 
approach to manipulate sperm production [53]. Strategies for the  generation of transgenic 
livestock with genetic manipulation of germ cells via transduction, prior to grafting, may 
also prove promising [9]. 
2.2.2.3 Xenografting of porcine, ovine, and caprine testis tissue  
Porcine, ovine, and caprine neonatal testis tissue xenografting into mice was reported to 
produce complete spermatogenesis, comparable to the cellular developmental trend of the 
intact testes [6, 13]; however, irregular formation of some seminiferous tubules in porcine 
xenografts was reported by Honaramooz et al. (2002) [6]. Moderate acceleration by a few 
weeks in testis maturation and sperm production were remarkable characteristics of both 
porcine and ovine testis tissue xenografting [6, 54]. Moreover, porcine and caprine 
xenografts developed efficient spermatogenesis along with quantitatively comparable 
sperm production per gram of tissue to that of testes in situ [6]. Xenogeneic pig and goat 
sperm obtained from testis grafts were able to fertilize oocytes [6, 12]. It is believed that 
the duration of cellular events in spermatogenesis is inherited [55]. Zeng et al. (2006) 
proposed that the acceleration of development in porcine and ovine testis tissue xenografts 
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could be due to gonadotrophin stimuli leading to a reduction in the time required for testis 
maturation rather than the duration of cellular events in spermatogenesis [54]. 
Porcine testis xenografts were suggested to be a preferred model for investigation of gene 
expressions in the testis because the profile of gene expression in xenografts was similar to 
that of porcine testis in situ [56]. This model could provide a useful approach for the 
manipulation of spermatogenesis and the study of gene expression during different stages 
of growth, proliferation and differentiation of porcine germinal cells.   
2.3 Xenografting of non-human primates and human testis tissue 
2.3.1 Xenografting of non-human primate testis tissue 
Xenografts of premature rhesus monkey (Macaca mulatta) testis tissue in recipient mice 
displayed a remarkably high recovery rate and significant growth. Histological evaluation 
at different time points after xenografting exhibited normal spermatid morphology along 
with a typical increase in the diameter of the seminiferous tubules. Surprisingly, 
accelerated lumen formation with significant shortening of the time required for testis 
maturation and complete spermatogenesis was noted in rhesus monkey testis tissue 
xenografts [8]. In the same report, rhesus monkey testis tissue xenografts from a one year 
old donor developed unusually rapid maturation in only seven months after grafting; 
giving them the same appearance as fully mature four year old control testes. Honaramooz 
et al. (2004) also found that supplementation with exogenous recombinant rhesus 
gonadotrophins was not necessary and rhesus testis tissue was responsive to mouse 
gonadotrophins [8]. Assessment of fertility competence of the recovered sperm from 
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prepubertal primate xenografts was performed via ICSI of rhesus monkey oocytes 
followed by the evaluation of the pronucleus and blastocyst formation. The xenogeneic 
sperm were found to be completely functional and capable of supporting embryo 
development as verified by parentage analysis [8].  
Unlike the rhesus monkey, marmoset monkey (Callithrix jacchus) testis xenografting did 
not proceed beyond germ cell meiosis [47]. Testis development was arrested at pre-
meiotic phase and no androgen was detected in the serum of recipient mice [7], even after 
co-grafting of marmoset and hamster testis tissues [47]. However, Honaramooz et al. 
(2003) suggested that poor graft development in marmoset monkeys is likely attributed to 
a mutation on exon 10 of LH receptor gene. This may lead to the lack of responsiveness to 
recipient mouse LH in marmoset testis tissue xenografts [57]. Induction and maintenance 
of germ cell differentiation after autologous testis grafting in marmosets verified the 
specificity of these unique LH receptors in this species [58]. 
Successful testis xenografting from prepubertal primate testes was considered promising 
for future fertility preservation and restoration in prepubertal cancer patients. 
2.3.2 Xenografting of human testis tissue 
Xenografting of immature testis tissue from several species into recipient mice has 
encouraged many studies with human testis xenografting, with the intention to conserve 
and restore fertility. Exposure of the testes to chemotherapic agents or total body 
radiotherapy for the purpose of harming propagating malignant cells, could inevitably 
affect healthy cells involved in proliferation. Thus, spermatogenic deficits and infertility 
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are consequential challenges for cancer patients [17]. Semen cryopreservation before 
fertility-compromising treatments, while not applicable in prepubertal boys, is an option 
for adult patients [17, 59]. Testis tissue xenografting is, therefore, a convincing theoretical 
approach with the potential for the restoration of fertility in prepubertal cancer survivors. 
Additionally, unlike germ cell transplantation, testis tissue xenografting with recovery of 
sperm from graft recipients would circumvent the possibility of re-introduction of 
neoplastic cells into the patient [17, 59]. At present, ethical concerns serve to constrain the 
source and availability of human testis tissue for xenografting studies. 
Schlatt et al. (2006) used a readily available source of human testis tissue from adult 
individuals who had undergone testis biopsies for infertility treatments. This study was 
also able to use whole testes of transgender individuals undergoing castration. However, 
as might have been expected, ectopic grafting of adult human testis tissue into recipient 
immunodeficient mice resulted in insufficient graft recovery, lack of meiotic activity in 
germ cells, initiation of hyalinization in seminiferous tubules, and subsequent gradual 
sclerosis [60]. Steroidogenesis deficiency was also evident in adult human testis tissue 
xenografts [17, 60]. However, Schlatt et al. (2006) demonstrated superior survival of 
spermatogonia over advanced germ cells in adult human xenografts, even after germinal 
cell regression caused by cytotoxic treatment prior to xenografting [60]. Nonetheless, the 
chance of survival and developmental potential of xenografts from prepubertal boys 
remains unknown.  
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Although testis tissue xenografting has improved during recent years, this alternative 
approach is not a viable method for fertility protection and restoration of prepubertal boys 
due to ethical concerns. Although merely experimental, there have been innovative 
breakthroughs in the storage of spermatogenic cells by cryopreservation. Cryopreservation 
of prepubertal testis biopsies and xenografting at a later date, or xenografting of fresh 
testis tissue followed by cryopreservation of resultant spermatids or spermatogonia, offer a 
theoretical alternative for fertility preservation of prepubertal boys to circumvent the risk 
of cancer relapse [17]. The first study on the survival and developmental capacity of testis 
tissue xenografts from cryptorchid young boys was conducted by Wyns et al. (2007) [25]. 
They demonstrated a reduction in spermatogonial cells in recovered grafts, but similar cell 
proliferative activity of spermatogonial and Sertoli cells of both cryopreserved and fresh 
tissue xenografts was retained [25]. Nonetheless, the hazard of viral infections and / or 
unknown zoonotic risks which may give rise to an epidemic, as well as ethical issues are 
serious concerns that need to be considered prior to clinical application of this technique 
[25, 60]. 
2.4 Xenografting of cryopreserved testis tissue 
The use of cryopreserved neonatal and prepubertal testis tissues from pig and hamster and 
recently prepubertal boys for xenografting has been reported [6, 7, 25]. Although 
preliminary in scope, the outcomes were promising. However, a qualitatively optimal 
technique specifically developed for testis tissue cryostorage is not yet available. In order 
to improve practical cryopreservation of testis tissue, efficacious cryoprotectants, less 
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damaging methods of freezing and thawing, and safe techniques of tissue handling are 
required. Cryostorage is a breakthrough strategy in testis tissue banking for cancer 
patients; even though associated risks of neoplastic recurrence, safety and ethical 
challenges of xenografting, and many unknown interrelated issues are areas of high 
concern. 
2.5 Relevance of testis tissue xenografting 
Testis xenografting could facilitate the experiments on large animals or primates by 
performing ectopic grafting of donor testis tissue into immunodefficient mice, which 
offers a major step forward, both ethically and logistically. The in vivo study of 
spermatogenesis using testis tissue xenografts is more cost-effective, could minimize the 
generation of inconsistent data due to the individual variation in target species [11]. The 
study and manipulation of spermatogenesis and steroidogenesis by changing the hormonal 
milieu in recipient mice is a far more versatile and practical approach than the in situ 
approach in larger animal models and humans [6, 8]. It is, for example, possible to easily 
castrate a recipient mouse and if necessary, also perform hypophysectomy to remove the 
influence of major reproductive hormone by the recipient mouse, and to supply any 
combination of exogenous hormones to study their effects on testis tissue xenografts. This 
technique also has the potential to save and manage present genetic diversity, especially in 
rare and endangered species. Assisting the movement of genetic material between animals 
of the same species by means of testis xenografting might provide a solution for the 
preservation of endangered species and to prevent a biodiversity crisis [10].   
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The successful application of xenografting could offer a robust alternative to the cloning 
of genetically valuable species. Animal cloning via nuclear transfer has been successful in 
several species, although technical challenges of this technique might limit routine 
expansion into other species. Other problems of cloning such as a low success rate and 
high mortality of cloned animals, can be avoided by grafting [61]. In fact, cloning is not a 
prudent option for increasing the number of individuals for an endangered species as it 
does not provide genetic diversity. Xenografting is a technique that can provide millions 
of genetically unique sperm produced in a graft, ensuring diversity in endangered species. 
Xenografting of testis tissue from experimental animals can also offer the possibility of 
germ cell development and gametogenesis from resourceless animals such as cloned, 
neonatally lethal, mutant, transgenic or knock-out animals [6, 61]. Moreover, innovative 
techniques of gene incorporation, using for instance, viral vectors or electroporation into 
spermatogonial stem cells can lead to expression of the transgene(s) of interest in sperm. 
Genetic manipulation of male germ cells in vitro followed by xenografting of testis tissue 
may offer a potential alternative for production of transgenic sperm for scale up 
production of transgenic livestock [9].  
In summary, xenografting of testis tissue could introduce new strategies in the 
conservation and propagation of genetic material by allowing complete spermatogenesis 
to occur in grafts from newborn or premature animals of different species into 
immunodeficient mice. Obtaining donor-derived fertility-competent sperm in recipient 
mice might provide practical methods for protection of rare or endangered species. 
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Restoration of germ lines of otherwise resourceless animals that die prematurely has 
provided proof of principle for future practical use of testis tissue xenografting. Reduction 
of repeated sampling from different individuals and consistency of outcome, are some of 
the possible applications of testis tissue xenografting from large animal or primate donors. 
This technique is potentially applicable to fertility preservation of cancer patients 
undergoing whole-body radiotherapy or cytotoxic chemotherapy. However, the ethical 
issues and safety concerns would have yet to be resolved.  
II. TESTIS TISSUE CRYOPRESERVATION 
2.6 Introduction to cryopreservation 
The survival secret for overwintering of certain insects and some arctic fish, or other 
native inhabitats of frozen parts of the world, is their ability for cryoprotection [62, 63]. 
The study of their freezing tolerance or cryo-injury avoidance phenomena could help us 
understand the underlying protection mechanism and possibly devise methodologies for 
cryopreservation. Cryostorage has been a topic of interest especially in fertility 
preservation for which banking of gonadal cells and tissues is critical for future 
experiments or diagnoses. To date, many different cryopreservation strategies have been 
proposed or developed to serve as a mechanism to restore all functional properties of the 
cryopreserved cells and tissues.  
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The first successful cell cryopreservation was carried out by accidental freezing of fowl 
sperm in diluents containing glycerol [64]. Later on, cryopreservation of bull sperm using 
the same cryoprotectant, revolutionized the bovine artificial insemination industry [65, 
66]. At about the same time in the early 1950‟s, cryopreservation of unfertilized oocytes 
was also studied following exposure to glycerol and low temperatures [67]. After initial 
success with in vitro embryo manipulation in the 1950‟s [68], research involving embryo 
freezing intensified. Many methods have been developed for embryo cryopreservation. 
Some have become routine procedures since the 1980‟s [69-71]. Cryopreservation of 
mature oocytes has also been achieved in recent years [72-74], with high survival rates 
and development of normal pregnancies after IVF (in vitro fertilization); however, the 
technique has been neither simple nor convenient. 
The first gonadal tissue cryopreserved successfully was ovarian tissue, resulting in 
preservation of cell viability and normal function [75]. In some cases, cryopreservation of 
structurally intact tissues could be more beneficial than cryopreservation of cells, 
especially when it is equally important to retain all of the tissue‟s potential. However, 
providing a robust freezing protocol to maintain all the compartments of the tissue could 
be more complicated. Rodent ovarian tissue was cryopreserved successfully after exposure 
to glycerol and autografted back into the animals [75-77]. Subsequent reports of live rat 
offspring, sheep ovarian cyclic function, and pregnancy after freezing the ovary prior to 
grafting, represented the first important steps demonstrating the feasibility of this approach 
[78, 79]. Cryopreservation of testis tissue prior to its grafting has also yielded complete 
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spermatogenesis [6, 7]. Restoration of spermatogenesis was also obtained after 
cryopreserved testis cells were transplanted into recipient testes [3, 20, 80]. Major 
advances have been made in the cryopreservation of reproductive tissues. The following is 
a review of the primary contributing factors for optimal cryopreservation and the possible 
applications of cryopreservation in future experimental and clinical settings in 
reproduction medicine.  
2.7 Biophysics of cryopreservation  
A clear understanding of cellular biophysical behavior at the time of cooling and exposure 
to different cryoprotectants is critical to improve the cell structural and functional potential 
after freezing. At slow cooling rates, extracellular ice crystal formation begins with the 
presence of a nucleation site in the extracellular medium. Since ice is pure crystalline 
water, the extracellular space becomes hypertonic due to the removal of water, as ice 
crystals develop. Intracellular water, therefore, moves outward across the cell membrane 
due to the differential osmotic gradient, and cells dehydrate and shrink. This is the 
opportunity when certain cryoprotective compounds could come into play and permeate 
the cells to protect them against high solute concentration or ice crystal damage. Since 
various cryoprotectant agents (CPA) permeate different types of cells at varying rates, it is 
of great benefit to understand the biophysics of cryopreservation to minimize damages 
[81, 82]. 
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Vitrification is a method of cryopreservation in which cells or tissues are exposed to high 
concentrations of CPA and high freezing rates. This technique prevents ice crystal 
formation, which is one of the major damaging consequences of freezing. The optimal 
CPA concentration and exposure time to prevent toxicity in different cell types also needs 
to be addressed specifically for each cell and tissue type. It is, therefore, critical to 
consider the biophysical theories behind different freezing protocols to minimize 
intracellular ice formation, risk of toxicity of CPA, solution effects and osmotic shock [81, 
82]. 
2.8 Freezing injuries 
2.8.1.  Ice crystal damage  
When live cells are subjected to freezing, many of them will suffer from damages caused 
by the cryopreservation process. Ice formation is one of the biophysical changes which 
causes irreversible breakdown of cells and tissues [81]. Due to the destructive effects of 
intracellular ice formation, conventional approaches to cryopreservation as yet, have not 
proven suitable for multicellular tissues [83]. Unlike cell suspensions, the highly organized 
structure of the tissue may vary in its response to cryopreservation; therefore, distribution 
of ice formation could be extremely hazardous to the complex tissue structure [84, 85]. Ice 
formation, initiated in the extracellular space, leading to an osmotic gradient across the 
cell membrane, causing intracellular water to move toward the concentrated extracellular 
space surrounding the cells [86, 87]. Previous studies have revealed that optimal cooling 
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rates for various cell types are directly associated with the degree of water permeability of 
cell membranes at different temperatures during freezing [88, 89]. Freezing injury is also 
attributed to intracellular ice crystal formation and osmotic dehydration (solution effect) 
[86, 87].  
2.8.2. Osmotic changes  
Extracellular ice formation causes elevated solvent concentrations and cell dehydration. 
As ice grows, the excluded solutes cause hyperosmotic stress to cells. The so-called 
„freeze-dehydration‟ is another biophysical consequence of cryopreservation [81, 82, 86, 
87, 90]. Prolonged exposure to hypertonic conditions might permanently damage cell 
membranes and destabilize proteins [87]. However, a short exposure of cells to optimized 
concentrations of hypertonic media before freezing might protect them from supercooled 
water retention within cells and subsequent intracellular crystallization during freezing 
[87]. Where cooling is faster than optimal, intracellular ice formation could occur due to 
inadequate time for water to follow osmotic gradient across the cell membrane [81, 82, 
87]. The osmotic tolerance of cells is another critical factor to be considered during 
addition and removal of different cryoprotectants. Physical destruction, subsequent 
organelle disruption, and functional damage are some of the known consequences of 
intracellular ice formation [91].  
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2.9 Cryoprotectants: protection and toxicity 
The idea of cell and tissue preservation by adding cryoprotectants before freezing has been 
investigated for decades. Sufficient concentration of cryoprotectants could minimize ice 
crystallization and/or promote amorphous solidification (vitrification). Glycerol was 
introduced as a cryoprotective agent in 1949 by Polge et al. [64]. Later, cryoprotective 
properties of dimethyl sulfoxide (DMSO) were reported by Lovelock and Bishop (1959) 
[92]. These two cryoprotectants have mainly been used since then, as classic 
cryoprotective additives, although many other CPA products have also been introduced. 
Permeating CPAs such as DMSO, glycerol, methanol, propanediol, ethylene glycol, and 
dimethyl acetaldehyde, and non-permeating CPAs including sucrose, dextran, albumin, 
polyvinyl pyrollidone, and hydroxyethyl starch, have been shown to afford effective 
cryoprotection [86, 87]. As described below, cryoprotective agents are known to act 
through different pathways to protect cells against freezing injuries. 
2.9.1. Modulation of hydrogen bonding and interaction with water molecules  
Hydrogen bonding gives CPAs high solubility and high permeability across cell 
membranes [87]. 
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2.9.2 Salt-buffering effect  
During freezing, cells experience osmotic dehydration and shrinkage; therefore, the 
addition of CPAs into the cells, maintains salt dilution. Basically, CPA replaces water in 
cells, which dilutes the intracellular salts and prevents intracellular crystal formation. The 
amount of CPA and water that permeates into the cells depends on the concentration of 
permeable solutes and final cell volume. The properties of CPAs and those of cell 
membranes will influence the degree of cryoprotection for different cell types [81, 87].  
2.9.3 Stabilizing biomembrane critical macromolecules  
Under normal conditions, water stabilizes the membrane bilayers. Loss of water during 
cryopreservation may disrupt normal membrane permeability and damage the membrane 
itself. The CPAs stabilize proteins as well as phospholipid bilayers of cell membranes and 
help to protect the membrane against freezing and dehydration stresses [93]. Studies have 
collectively demonstrated that CPAs such as DMSO and disaccharide sugars such as 
sucrose and trehalose may electrostatically interact with membrane phospholipids to 
provide stabilization [94, 95].  
2.9.4 Scavenging oxygen free radicals  
CPAs may prevent oxygen free radicals and oxidative stress to the cells [87]. CPAs block 
the action of unstable intermediate products, such as oxygen free radicals, by binding their 
hydrogen atoms to them [96, 97]. 
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2.9.5 Inhibition of nucleation  
Ice formation occurs in the media through nucleation. During cooling, initial 
heterogeneous nucleation sites, such as small particles, change in shape and increase in 
size within media reaching a stage that forms ice crystals. Alternatively, induced 
nucleation could be beneficial to provide consistent extracellular crystallization. This is the 
basis for „seeding‟, which induces nucleation onto supercooled media enabling embryo 
cryopreservation [87]. Seeding can be achieved by clamping the side of vials or straws 
with a forceps cooled in liquid nitrogen to stimulate the local ice growth into the solutions. 
Intracellular nucleation can also be lethal or damaging for cells and tissues. Some CPAs 
such as DMSO or glycerol inhibit nucleation by increasing the high viscosity of 
intracellular  water [87]. Non-permeating CPAs, on the other hand, increase and promote 
cellular dehydration by increasing the extracellular solute concentration, thereby reducing 
intracellular crystallization [86]. 
Despite the protective potential of CPAs, a side effect of the addition of CPAs is 
cytotoxicity. Tissue tolerance to CPAs is limited and overexposure to CPAs may cause 
damage [90]. However, toxicity is difficult to assess precisely [87]. Cytotoxicity is 
exacerbated by increasing CPA concentration during ice formation [90]. It is believed that 
optimizing the freezing rate and rates of CPA addition and removal could reduce the 
toxicity of CPAs [90].  
 
 35 
 
2.10 Cryopreservation techniques  
Finding the optimal cryopreservation protocol for certain cells and tissues depends on the 
application of a proper cryoprotectant, and cooling rate. Critical factors for effective 
cryopreservation such as cell permeability to water or CPA, and subsequent osmotic 
changes, are directly affected by the rate of cooling [89]. Prolonged overexposure to 
hypertonic conditions leads to osmotic stress, cell shrinkage, and irreversible membrane 
and protein impairment [87].  
The alternative route which avoids ice crystal formation and solute damage is 
transformation of aqueous milieu to the amorphous character of a glassy state, known as 
vitrification. Vitrificaiton involves exposure of tissue to extreme viscosity CPAs and 
ultrafast freezing [82, 87, 90]. However, this approach is compromised by the cytotoxic 
effects of CPAs during lengthy periods of exposure, and osmotic effects on cells [81, 87].  
To deal with this problem, some researchers have suggested using a combination of CPAs 
to improve vitrification. Proper media may include disaccharides such as sucrose or 
trehalose, and proteins or polymers [98, 99].  
2.11 Thawing methods  
Optimal thawing and CPA removal are critical factors for survival after freezing [86]. 
Earlier studies pointed out that consistent cooling and thawing rates (slow-freezing / slow-
thawing and fast-freezing / fast-thawing) might improve cell and tissue survival after 
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cryopreservation [71]. Moreover, osmotic changes during CPA removal might damage the 
cells by extensive cell shrinkage or swelling associated with the rapid movement of water 
into the cell as compared to slower movement of CPA out of the cell [82]. Limited amount 
of water replacement, however, is needed to restore osmotic equilibrium and physiologic 
cell volume [82].  
2.12 Applications of cryopreservation in reproduction medicine 
Development of cryoconservation methods for long-term storage of cells and tissues is 
critical for ex situ preservation of biological diversity and to maintain genetic stability in 
different species. There has been a substantially increased interest in biomedical research 
on infertility. Assisted reproductive technologies (ART) are some of the prominent 
features of clinical therapies [86], although many unsolved problems have remained. 
Preservation is one of the major challenges of routine ART, since short-term or long-term 
storage is required where immediate use of fresh cells or tissues is not desired or possible. 
To deal with fertility concerns in cancer patients, preservation of sperm, zygotes, embryos, 
or ovarian tissues is a common practice [100-103]; however, cryopreservation techniques 
for unfertilized oocytes, ovarian, and testis tissue, need to be improved for routine use in 
prepubertal individuals.  
Ovarian and testis toxicity are the inevitable long-term consequences of certain therapeutic 
oncological regimens, leading to premature fertility failure or sterility in cancer patients 
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[59, 104, 105]. Gonadal cells or tissue cryopreservation before high-dose gonadotoxic 
chemo- and radiotherapy could be beneficial [86, 105]. 
Cryopreservation of testis tissue or cell suspensions could be an alternative fertility option 
for prepubertal boys with cancer or azoospermic men, since spermatogenesis is not 
completed in these patients [34, 106]. Reversible suspension of testis tissue growth and 
development via cryopreservation is currently under extensive investigation. Salvaging 
genetic potential through banking of gonadal tissues is also an issue of clinical 
significance in animal reproduction. Optimal cryoconservation methods could also be 
combined with transplantation or xenografting techniques to overcome some of the 
complications in the biodiversity crisis of rare or endangered species [10]. In fact, 
experimental methods for the generation of fertility-competent gametes from 
cryopreserved ovarian or testis tissue have paved the way for future clinical use. Searching 
for optimal techniques for reproductive cell and tissue cryopreservation is an exciting 
endeavour in current reproductive science and technology. Although, successful gamete 
and gonadal tissue restoration could have huge impact on the enhancement of fertility 
preservation, serious ethical implications associated with collection and preservation of 
human gametes and gonadal tissues have yet to be resolved.  
theIn summary, experimental gonadal tissue and cell conservation by cryopreservation can 
serve a platform for further evaluation of the potential for long-term storage. After 
discovering the cryoprotective effects of glycerol and DMSO, several other cryoprotective 
agents have also been proposed and widely used for cryoconservation. Many challenges 
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are associated with the optimal maintenance of tissue structure and the subsequent 
functional restoration of cryopreserved samples. Optimal osmotic conditions, cooling and 
thawing rates and cryoprotectant concentrations are crucial elements that need 
investigation.  
Based on this information, we propose to investigate testis tissue xenografting and to 
determine the enhanced preservation conditions of immature testis tissue. This may 
provide a novel insight into the study, manipulation, and restoration of male fertility in 
different species.   
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HYPOTHESES AND OBJECTIVES  
 Hypothesis 1: Xenografting of testis tissue from donor dogs into recipient mice will 
result in the establishment and maintenance of spermatogenesis in testis tissue 
xenografts. 
 Objective 1: To investigate testis tissue xenografting from donor dogs into recipient 
mice. 
 Hypothesis 2: Grafted testis tissue from immature and young donors will have 
superior recovery, growth and development to that of adult donors. 
 Objective 2: To examine the effect of donor age on progression of spermatogenesis in 
dog testis tissue after xenografting into recipient mice. 
 Hypothesis 3: Short-term refrigeration or long-term cryopreservation of donor piglet 
testis tissue prior to xenografting will maintain the developmental potential of testis 
tissue xenografts. 
 Objective 3: To test the effects of short-term refrigeration or long-term 
cryopreservation of immature porcine testis tissue on its survival and developmental 
potential. 
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CHAPTER 3: THE EFFECT OF DONOR AGE ON PROGRESSION OF 
SPERMATOGENESIS IN CANINE TESTIS TISSUE AFTER XENOGRAFTING 
INTO IMMUNODEFFICIENT MICE  
3.1 Abstract 
The purpose of this study was to examine the effect of donor age on progression of 
spermatogenesis in dog testis tissue after xenografting. Testes of dogs 2.5 to 22 months of 
age were obtained by surgical castration. Donors were categorized based on 
developmental pattern of spermatogenesis at the time of grafting. Immature, young, and 
adult categories corresponding to less than four months, four to six months, and greater 
than six months of age, respectively were established. Fragments of testis tissue were 
implanted under the back skin of immunodeficient nude mice. The xenografts were 
retrieved and analysed at intervals of four, six and eight months after grafting. At four 
months post-grafting, immature and young groups had higher graft recovery rates (92 ± 
5.8 and 88 ± 4.4% versus 69 ± 3.5%; P = 0.001 and P = 0.001), graft weights (34 ± 8.1 and 
32 ± 11.0 mg versus 7 ± 2.6 mg; P = 0.001 and P = 0.022), vesicular gland indices (1.1 ± 
0.20 and 0.6 ± 0.18% versus 0.1 ± 0.03%; P < 0.0001 and  P = 0.015), seminiferous tubule 
numbers (517 ± 114.8 and 364 ± 161.0 versus 10 ± 5.1 ; P < 0.0001 and P = 0.028), and 
larger seminiferous tubular diameters (140 ± 17.8 and 130 ± 3.4 µm versus 55 ± 21.9 µm; 
P = 0.003 and P = 0.001) compared to adult donor xenografts. Immature donor xenografts 
maintained the growth, and development for eight months as exhibited by greater graft 
weights (17 ± 4.6 mg, P = 0.002), vesicular gland indices (1.5 ± 0.46%, P = 0.0005), 
seminiferous tubule numbers (547 ± 210.3, P < 0.01) and tubular diameters (93 ± 15.9 µm, 
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P < 0.0001) compared to adult donor xenografts.  The growth and development of testis 
tissue xenografts from immature and young donors were not different after eight months 
(P > 0.05). Young donor xenografts had greater seminiferous tubule number and diameter 
compared to adult donor xenografts (P = 0.009 and P = 0.004, respectively) at eight 
months post-grafting. Elongated spermatids were the most advanced germ cell type 
present at four and eight months post-grafting in immature and young age groups. This 
study showed that immature and young donors (less than six months of age) were the most 
promising donors for testis xenografting, offering a potential alternative for male germ line 
preservation for canids that die prematurely or must be castrated before maturation. 
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3.2 Introduction 
Reversible suspension of testis cells and tissue growth and development has been tested 
using different approaches [102]. The purpose of these studies was to propagate and to 
manipulate gonadal tissue for fertility restoration. Ectopic grafting of testis tissue into 
recipient mice has allowed for the maturation and the establishment of spermatogenesis in 
grafts of a variety of species including mouse, hamster, rabbit, bull, horse, pig, goat, cat, 
monkey, and sheep [6-13]. The results from testis tissue xenografting in different studies 
also varied depending on the donor species and age, but generally have led to the 
induction of spermatogenesis with dynamics similar to those of the donor species. 
Recovered sperm from the grafts have been shown to be fertilization-competent [6, 8, 12].  
Testis tissue xenografting could be of great benefit, especially from immature donors 
where other techniques such as cryopreservation of ejaculated sperm to preserve an 
individual‟s fertility are not applicable [59]. Many characteristics of spermatogenesis and 
steroidogenesis can also be examined using this in vivo model, since all the compartments 
of testis tissue remain intact.  
Despite the range of species that have been used as donors in testis tissue xenografting, 
there are no reports from canine donors. Dogs kept as pets, are usually castrated at about 
six months of age; however, some dog owners may later regret the decision, wishing they 
could produce offspring from their favorite dog. For this reason, commercial cloning of 
pets has become a popular viable option, although it is costly and technically demanding. 
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Preservation of the testes after castration, however, may offer an alternative since 
xenografting of preserved tissue could generate viable sperm even from neonatal donors. 
Furthermore, survival of threatened or endangered species is dependent upon conservation 
of the existing biodiversity within wild life isolated populations [107]. The movement of 
genetic materials from wild animals maintained in captivity or protected areas is especially 
challenging [107]. Testis tissue xenografts from neonatal donor males could offer a 
previously unavailable option to produce gametes from captive or free animals facing 
premature death. Xenografting has already offered an alternative method for preservation 
and re-establishment of prepubertal testis development in felids [10, 49]. For cats, the 
most practical donor age was found to be prior to the onset of puberty [49]. The same may 
be true for many other domestic species [30]. However, testis maturation and normal 
spermatogenesis have not been comprehensively studied using a range of donor ages and 
particularly not for the canine species.  
Among canids, the Ethiopian wolf (Canis Simensis) is believed to be the most endangered 
canine species in Africa with only about 400 surviving [108]. Therefore, investigation of 
canine testis tissue xenografting could provide a new insight into fertility restoration of 
domestic and wild life canids. 
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3.3 Materials and methods 
3.3.1 Study design 
Dog testes from donors of different ages were obtained following surgical castration. 
Fragments of testis tissue were grafted under the back skin of castrated immunodeficient 
mice. Half of the recipient mice received exogenous gonadotrophins. The mice were 
sacrificed at four, six or eight months following grafting. Xenografts were retrieved to 
assess their recovery rate, weight, and histological characteristics. Vesicular gland weights 
of recipient mice were obtained to indirectly evaluate the testosterone output of 
xenografts. 
3.3.2 Donor animals and testis tissue preparation 
Testes of 12 dogs were obtained after routine surgical castration at the Small Animal 
Surgery Service of the University of Saskatchewan or at a private clinic in Saskatoon, SK. 
The dogs were of mixed breeds (Table 3.1) and were 2.5 (n = 3 littermates), 3.5 (n = 2 
littermates), 4.5, 5.5, 7, 8, 10, 13, and 22 months of age (n = 1 donor each) at the time of 
castration. The testes were immediately transferred into Dulbecco‟s phosphate buffered 
saline without calcium or magnesium (DPBS, Cat# 20-031-CV; Mediatech, Herndon, 
VA). The DPBS was maintained on ice and transferred to the laboratory within 1 hour. 
After rinsing three times with DPBS supplemented with 1% antibiotic/antimycotic 
solution (10000 IU penicillin, 10,000 µg/ml streptomycin, 25 µg/ml amphotericin B; Cat# 
30-004-CI, Mediatech), the tunica albuginea and overt connective tissues were removed. 
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The donor testes were cut into small fragments approximately five mg in weight or two 
mm
3
 in volume. Testis fragments were kept in Dulbecco‟s modified Eagle‟s medium 
(DMEM; Cat# 50-003-PB; Mediatech) on ice until grafting. The xenografting procedure 
took place within two hours after castration. Comparable pieces of testis tissues were fixed 
in Bouin‟s solution overnight. They were washed with and stored in 70% ethanol solution. 
These fragments served as a reference for subsequent histological analysis of development 
in testis xenografts. The cross sections of seminiferous cord/tubules in each graft section 
were counted and measured (µm) to characterize the testis tissue xenografts at the time of 
grafting. 
3.3.3 Recipient animals and xenografting procedures 
Male immunodeficient nude mice (NCr, nu/nu, Taconic, Germantown, NY), four to six 
weeks of age at arrival, were used as recipient animals. Mice were housed in groups of 
four and maintained aseptically under controlled photoperiod conditions (lights-on 6 a.m. 
through 6 p.m.) with sterile water and mouse chow provided ad libitum. After surgical 
preparation and anaesthesia with intra-peritoneal injection of ketamine hydrochloride (100 
mg/kg; Ketalene, Bimeda-MTC, Cambridge, ON, Canada) and xylazine hydrochloride (10 
mg/kg; Vet-A-Mix, Shenandoah, IA), castration was performed. During the surgery, eight 
transverse linear incisions (about 0.5–1 cm in length) were made on the back skin of each 
mouse, four on each side. One testis tissue fragment was inserted under the subcutaneous 
fascia through each incision and the incisions were closed with stainless steel wound clips 
(Michel Clips 7.5 mm, Miltex, York, PA). Four to 15 mice were grafted per donor age. In 
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the case of donor littermates that were 2.5 and 3.5 months old, four to six recipient mice 
were grafted with tissue from each donor animal. Based on previous reports of successful 
testis tissue xenografting from premature donors, we decided to use a higher number of 
recipients for immature donors. In total, 53 mice received canine testis tissue xenografts 
(Table 3.1). All animal experimental procedures and subsequent treatments were carried 
out according to the guidelines of the University of Saskatchewan‟s Institutional Animal 
Care and Use Committee. 
3.3.4 Gonadotrophin treatment 
Half of the recipient mice per donor age were randomly assigned to receive gonadotrophin 
treatments as a pilot project to determine if exogenous luteinizing hormone (LH) and 
follicle stimulating hormone (FSH) would affect the growth and development of canine 
testis tissue xenografts. These mice were administered with 10 IU equine chorionic 
gonadotrophin (eCG, Folligon, Intervet, Whitby, ON, Canada) and 10 IU human chorionic 
gonadotrophin subcutaneously (hCG, Chorulon, Intervet). The remaining untreated mice 
served as control animals. The treatment started immediately after grafting and continued 
twice a week until the time of sacrifice at four, six or eight months after xenografting 
(Table 3.1).  
3.3.5 Analysis of recipient mice  
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Four months after grafting, two to three mice per donor were randomly selected and 
sacrificed to evaluate graft recovery rate, weight, and spermatogenesis status. Half of these 
mice were recipients of gonadotrophin treatment and half were control mice. This 
procedure was repeated at six months post-grafting for the mice carrying the 2.5 months 
old donor grafts. The remainder of donor testis tissue xenografts were retrieved at eight 
months post-grafting to further examine their growth and development (Table 3.1). At the 
time of sacrifice, mice were anaesthetized and sacrificed by cardiac bleeding. Vesicular 
glands were dissected out and weighed to calculate the vesicular gland index (vesicular 
gland weight / body weight), as a measure of biological testosterone activity. Grafts were 
recovered, weighed and fixed overnight in Bouin‟s solution followed by three washes with 
70% ethanol before histological processing. Fixed testis tissues were paraffin embedded, 
sectioned with a thickness of 7 µm at the largest cross-section and stained with 
hematoxylin and eosin. For histological analysis of the grafts, all seminiferous tubules in 
the largest cross-section of each testis graft were counted and measured. Histological 
assessment of testis tissue xenografts was performed using a microscope equipped for 
digital photomicrography (Northern Eclipse Image Analysis software, version 7.0, Empix 
Imaging, Mississauga, ON, Canada). 
Each slide was scored at 200X and 400X magnifications according to a previously 
described screening system [7], to characterize the incidence of developmental events 
present in each tubule cross section. The slides were anonymously labelled, and the 
operator blindly analyzed and scored all the tubular cross-sections of each xenograft. The 
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developmental patterns were scored as: (i) complete tubular degeneration and, or fibrosis 
and, or Sertoli cell only tubules; (ii) gonocytes and spermatogonia as the only germ cells; 
(iii) spermatocytes as the most advanced germ cells; (iv) round spermatids as the most 
advanced germ cells; (v) elongated spermatids as the most advanced germ cells; or (vi) 
mature sperm present in the lumen of the tubule. Data from different grafts within each 
mouse were averaged for the mouse and data are presented as the Mean ± SEM values for 
the group. 
3.3.6 Statistical analyses 
Donors were categorized by age and based on histological characteristics at the time of 
grafting. Categories were based on developmental pattern of spermatogenesis at the time 
of grafting. Immature, young, and adult categories corresponding to less than four months, 
four to six months and greater than six months of age respectively, were established. The 
outcomes of interest in this analysis included the mean graft weight, graft recovery rate 
(%), vesicular gland index (%), number of seminiferous tubules, and seminiferous tubule 
diameter (µm).  The differences in graft outcome were compared across age categories 
using generalized estimating equations (GEE) to adjust for use of grafts from the same 
donor on more than one recipient animal  (PROC GENMOD, SAS for Windows version 
9.1, SAS Institute, Cary, NC). The data were modeled assuming a normal distribution and 
the model included a repeated statement with subject listed as the donor identification. The 
residuals were examined for outliers and to assess the model assumptions of normal 
distribution and equal variance. All differences between age categories were considered 
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statistically significant where P < 0.05 and the data were expressed as mean ± SEM. Each 
recipient mouse was considered as an experimental unit. Mean seminiferous tubule 
diameter prior to xenografting was compared among different donor age groups by one-
way analysis of variance. No difference was observed in the growth, development or 
maturation between the gonadotrophin treated and control mice; therefore, the data from 
all recipient mice of the same donors were pooled. Table 3.1 summarizes our experimental 
data at xenografting.  
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            Table 3.1 Experimental data and histological analysis of donor testis tissue at the time of grafting.
Donor breed 
Donor age 
(months) 
No. of 
recipient mice 
per donor 
No. of testis 
xenografts per 
recipient mouse 
No. of mice in 
gonadotrophin 
treatments 
Graft period 
(months) 
Seminiferous tubule 
number per 5  mg tissue 
before grafting 
Seminiferous tubule 
diameter before 
grafting (µm) 
Boxer X 2.5 4 8 2 4 
6 
272±23.3 65±0.5
a
 
Boxer X 2.5 5 8 2 4 
6 
269±25.0 61±0.8
a
 
Boxer X 2.5 6 8 3 4 
6 
270±23.3 71±0.8
a
 
Miniature 
Poodle X 
3.5 4 8 2 4 
8 
132±16.0 63±0.8
a
 
Miniature 
Poodle X 
3.5 6 8 3 4 
8 
136±10.0 63±0.7
a
 
Chihuahua 4.5 4 8 2 4 
8 
138±15.5 98±1.3
b
 
Rottweiler X 5.5 4 8 2 4 
8 
150±19.5 140±2.4
c
 
Lab. Retriever 
X 
7 4 8 2 4 
8 
140±21.0 138±1.7
c
 
Chihuahua 8 4 8 2 4 
8 
75±4.0 169±2.5
d
 
Shih Tzu X 10 4 8 2 4 
8 
111±3.0 172±2.6
d
 
German 
shepherd X 
13 4 8 2 4 
8 
114±8.5 186±14.2
d
 
Shih Tzu X 22 4 8 2 4 
8 
168±26.5 156±2.9
e
 
Donors, recipients, and testis tissue xenograft properties prior to xenografting. ANOVA was used to compare the seminiferous tubule diameter of 
testis tissue xenografts.
 
Means with different superscript letters within columns are significantly different (P < 0.05). Data are presented as Mean ± 
SEM. 
 
5
0
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3.4 Results 
3.4.1 Graft recovery and growth 
From a total of 53 recipients, grafts were retrieved from 42 mice, while no grafts were 
detectable in eight mice. Three of the mice died prior to the scheduled time-points and 
were excluded from the analysis. Tables 3.2 and 3.3 summarize the data for testis grafts 
collected at four, six or eight months post-grafting. To simplify analyses and general 
trends, donors were categorized based on histological characteristics and developmental 
pattern at the time of grafting into: Immature (less than 4 months old) with spermatogonia 
as the only type of germ cells present; young (4-6 months old) with round spermatids as 
the most advanced germ cell type present; adult (more than 6 months old) donors with 
elongated spermatids as the most advanced germ cell type present. 
Graft recovery rate is defined as the relative percentage of detectable grafts collected at the 
time of sacrifice. At four months post-grafting, immature and young testis xenografts 
showed a higher recovery rate (detectable grafts) than adult donor grafts (P = 0.001), while 
no significant difference was detected between immature and young groups graft recovery 
rate (P = 0.57). Xenografts of 3.5 months age group had the highest numerical recovery 
rate (Table 3.2). Xenografts of greater than 6 months old donors had a varied graft 
recovery rate. Graft recovery rates at eight months post-grafting were not different among 
donor groups (P > 0.05) and generally had more variation (Table 3.3).  
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Testis tissues xenografts were about five mg at the time of grafting. At four months post-
grafting, immature and young donor groups did not differ in graft weight (P = 0.92), 
though revealed greater graft weight than adult donor xenografts (P = 0.001 and 0.02, 
respectively; Table 3.2). At eight months post-grafting, xenografts from immature donors 
had higher weight than those from adult groups (P = 0.002). Young groups did not 
significantly differ in graft weight from immature and adult donors (P = 0.59 and 0.14, 
respectively). In general, testis xenografts from adult donors had poor overall growth at 
both four and eight months post-grafting periods (Table 3.3). The exception to this was the 
eight months old donor that at four months post-grafting showed both low and high graft 
weight variations (6 to 27 mg). Testis tissue xenografts of 2.5 months old donor groups 
which were collected at six months post-grafting were 7 to 62 mg in weight (Table 3.3). 
At four months post-grafting, vesicular gland indices (percentages of the vesicular gland 
weight divided by the body weight) were generally higher in the mice carrying immature 
and young donor grafts than mice with adult donor xenografts (P < 0.0001 and P = 0.02, 
respectively). At this time point, however, no significant difference was evident between 
vesicular gland indices of mice carrying immature testis xenografts and mice with young 
donor grafts (P = 0.07; Table 3.2). At eight months post-grafting, mice carrying immature 
donor grafts had considerably higher vesicular gland indices than those in adult age groups 
(P = 0.0005). Mice with young age donor xenografts displayed no significant difference in 
the vesicular gland indices with those of immature or adult groups (P = 0.39 and 0.08, 
respectively; Table 3.3). Exogenous gonadotrophin treatment of the recipient mice did not 
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significantly alter the recovery and development of xenografts within age groups; 
therefore, the data were pooled for each age group. Gonadotrophin treatment also did not 
alter vesicular gland indices of the treatment group, compared to control mice carrying 
xenografts (P > 0.05).  
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Donors were categorized based on developmental pattern of spermatogenesis at the time of grafting. Immature, young, and adult categories 
corresponding to less than 4 months, 4-6 months and greater than 6 months of age respectively were established for statistical analysis. At 
four months post-grafting, these groups were compared in graft recovery (defined as the number of detectable grafts collected at the time of 
sacrifice), graft weight, seminiferous tubule number and diameter in the largest cross-sections of xenografts, and vesicular gland indices of 
the mice carrying the xenografts. Immature and young donors exhibited markedly greater values in all aspects than adult donors (P < 0.05). 
Data are presented as mean ± SEM. N/A = Not applicable, where grafts were detectable, but were either completely degenerated or had 
negligible graft weight changes, compared to the time of implantation.  
   Table 3.2 Characterization of dog testis tissue xenografts at four months after grafting. 
 
 
 
 
 
  
 
      Donor age          Graft recovery (%)        Graft weight (mg)               Seminiferous tubule #                   Graft  seminiferous               Vesicular gland 
      (months)                                                                                                         per graft cross section                    tubule diameter (µm)
                 
       index (%) 
 
 
 
               2.5                     90 ± 8.2                        41 ± 8.9                               597 ± 114.9                                     186 ± 4.6
  
                             1.18 ± 0.26 
 
               3.5                     97 ± 3.1                        36 ± 10.3                             546 ± 215.2                                     124 ± 1.7
  
                             0.97 ± 0.29 
 
            4.5                      94 ± 6.3                       18 ± 3.9                                591 ± 339.5
 
                                    125 ± 2.7
 
                              0.83 ± 0.45 
            5.5                      81 ± 6.3                       82 ± 22.0                              136 ± 64.0
 
                                      138 ± 3.3
 
                              0.3 ± 0.29 
             7                        63 ± 12.5                        N/A                                        N/A                                             N/A                                      0.08 ± 0.05 
             8                        63 ± 25.0                      39 ± 32.9                            22 ± 5.5                                           125 ± 6.0
 
                               0.1 ± 0.03 
            10                       69± 6.3                         7 ± 0.2
   
                              52 ± 0.0
 
                                          156 ± 6.9
 
                               0.23 ± 0.13 
            13                       75 ± 0.0                            N/A                                          N/A                                              N/A                                  0.04 ± 0.0 
 
            22                       81 ± 6.3                         6 ± 0.7
   
                             28 ± 24.0                                         111 ± 3.7
  
                              0.07 ± 0.04   
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     Table 3.3 Characterization of dog testis tissue xenografts at six or eight months post-grafting.  
 
 
 
  
 
 Donor age          Graft recovery (%)        Graft weight (mg)         Seminiferous tubule #            Seminiferous                          Vesicular gland  
     (months)                                                                                               per graft cross section          tubule diameter (µm)
                 
          index (%) 
            2.5
*  
               97 ± 3.8
*
                         52 ± 9.0
 
*                     669 ± 242.5*                            --                                              0.96 ± 0.29
*
 
            3.5                  88 ± 7.2                         26 ± 2.4
 
                         670 ± 233.6                          124 ± 2.2
 
                                     1.70 ± 0.61
 
 
            4.5                 19 ± 18.8
 
                       19 ± 0.0
 
                         67 ± 66.5
 
                             119 ± 3.7
 
                                      0.32 ± 0.27 
            5.5                  94 ± 6.3
 
                        52 ± 8.1
 
                        217 ±1.5                                134 ± 3.7
 
                                     1.45 ± 0.02
 
 
             7                    56 ± 6.3
 
                        12 ± 1.9                         100 ± 35.0
 
                             117 ± 2.8                                     0.25 ± 0.05
 
 
             8                    56 ± 18.8                        N/A                                 N/A                                     N/A                                             0.48 ± 0.02 
            10                  50 ± 12.5
 
                       5 ± 1.5                              N/A                                     N/A                                             0.03 ± 0.01
 
 
            13                   N/A                               3 ± 0.0                              N/A                                     N/A                                             0.14 ± 0.05
 
 
            22                  75 ± 12.5
 
                       1.5 ± 0.0                       20 ± 19.0                               144 ± 6.7
 
                                      0.10 ± 0.06
 
 
Donors were categorized based on developmental pattern of spermatogenesis at the time of grafting. Immature, young, and adult 
categories corresponding to less than 4 months, 4-6 months and greater than 6 months of age respectively were established for statistical 
analysis. At eight months post-grafting, these groups were compared in graft recovery (defined as the number of detectable grafts 
collected at the time of sacrifice), graft weight, seminiferous tubule number and diameter in the largest cross-sections of xenografts, and 
vesicular gland indices of the mice carrying the xenografts. Immature and young donors exhibited markedly greater values in all aspects 
than adult donors (P < 0.05). Data are presented as mean ± SEM. N/A = Not applicable, where grafts were detectable, but were either 
completely degenerated or had negligible graft weight changes, compared to the time of implantation. Asterisks indicate mice that were 
sacrificed at six months after grafting, while other groups were sacrificed at eight months after grafting.  
  
  
  
  
  
  
A
d
u
lt
  
  
  
  
  
  
  
 Y
o
u
n
g
  
  
  
 I
m
m
a
tu
re
  
  
  
  
  
  
  
 
  
5
5
 
  
 
56 
 
3.4.2 Histological analysis 
 3.4.2.1 Tubular morphology 
At the time of grafting, immature donor testis tissues contained seminiferous cords with 
Sertoli cells and gonocytes / spermatogonia as the only germ cell types present. Interstitial 
tissue contained immature Leydig cells (Fig. 3.1 and 3.4A). The tissue from older donors 
displayed varying degrees of germ cell differentiation. Spermatocytes were mainly the 
most advanced germ cell types in young donors. Elongated spermatids or sperm were the 
most advanced germ cell type present in adult donor xenografts (Fig. 3.1 and 3.4G). 
At four months post-grafting, seminiferous tubules of immature donors exhibited initiation 
of spermatogenesis with spermatocytes being the most abundant (Fig. 3.2). Round 
spermatids were the most advanced germ cells in the
 
2.5
 
months old donor groups, while 
elongated spermatids were the most advanced germ cell type in the 3.5 months old donor 
group (Fig. 3.2 and 3.4B). Among young donor groups, 4.5 months old donor xenografts 
revealed re-initiation of development and spermatogenesis up to formation of elongated 
spermatids. In contrast, 5.5 months old donor xenografts showed more than 60% 
degenerative tubules and spermatocytes as the most prevalent types of germ cells (Fig. 
3.4E and 3.2). In adult donor xenografts, the majority of seminiferous tubules displayed 
degenerative changes as a common feature. Degenerative changes with fibrosis and 
vacuolization of seminiferous tubules were observed in 54 to 100% of the seminiferous 
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tubules. Round spermatids were identified as the most advanced germ cell types in 3% of 
seminiferous tubules in
 
10 months old donor xenografts (Fig. 3.2 and 3.4H). 
At six or eight months post-grafting, from 2.5 and 3.5
 
months old donors, the established 
spermatogenesis had continued to develop round and elongated spermatids as the most 
advanced germ cell types (Fig. 3.3 and 3.4C). Tubules from one of the three 2.5 months 
old donors showed complete degeneration. The grafts from the 4.5 months old donor 
contained no differentiated germ cells after eight months of grafting (Fig 3.4F). On the 
other hand, grafts from donors older than 5 months contained variable degrees of 
development and tubular degeneration. The 5.5 and seven months old donor grafts 
displayed more than 50% spermatocytes, and 2-3% round spermatids as the most 
advanced germ cells. Moreover, at eight months post-grafting, grafts from adult donors 
showed complete tubular degeneration with partial recovery of a few seminiferous tubules 
only in the 22 month old donor group (Fig. 3.3 and 3.4I). Figure 3.4 shows representative 
histological appearances of testis tissue xenografts before and after grafting.  
3.4.2.2 Tubular number 
The average number of cross sections of seminiferous cords or tubules in the widest cross-
section of grafts was determined for each age group, pre- and post-grafting. At four 
months post-grafting, no difference was indicated in number of seminiferous tubule 
sections between testis grafts of immature and young donor groups (P = 0.44), although 
these groups contained a greater number of tubule sections than adult donor groups (P < 
0.0001 and P = 0.03, respectively).  
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At eight months post-grafting, testis grafts obtained from immature and young donor dogs 
had markedly increased numbers of seminiferous tubule cross sections than those of adult 
donors (P = 0.01). Grafts of 2.5 months old donors were examined at six months post-
grafting to verify the continuance of testis xenograft growth and proliferation status 
between the four and eight months periods. After six months of grafting, the number of 
seminiferous tubules of 2.5 months old donors were comparable to that of 3.5 months old 
donors at eight months post-grafting (P = 0.45). 
3.4.2.3 Tubular diameter 
Seminiferous tubule diameter was also measured to examine the impact of donor age on 
histological characteristics of the grafts. At the time of grafting, immature donor testes 
exhibited smaller seminiferous tubule diameters as compared with those of older donors (P 
< 0.001, Table 3.1). There was increased seminiferous tubule diameter as donor age 
increased (P < 0.001). Testes from adult donors contained the largest seminiferous tubule 
diameters at the time of grafting (P < 0.001, Table 3.1).  
At four months post-grafting, immature and young donor grafts exhibited greater 
seminiferous tubule growth compared to adult donor groups (P = 0.003 and 0.0008, 
respectively). At four months post-grafting, testis grafts from immature and young groups 
exhibited seminiferous tubule diameters comparable to those in the intact mature testis 
(Table 3.2). At eight months post-grafting, the recovered immature and young donor 
xenografts had markedly higher tubular diameters than those of adult donor grafts (P < 
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0.0001 and P = 0.004, respectively). Immature and young donor grafts did not exhibit any 
difference in tubular diameter after eight months of grafting (P = 0.91, Table 3.2 and 3.3).  
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Figure 3.1 The most advanced germ cell types prior to grafting.  
Donors were categorized based on developmental pattern of spermatogenesis at the 
time of grafting. Donor categories correspond to immature, young and adult (< 4, 4-6, 
and > 6 months old, respectively). Histological appearance of testis tissue xenografts 
was scored based on the percentages of seminiferous tubule cross sections with Sertoli 
cell only or with spermatogenesis containing the cells specified as the most advanced 
germ cell types present. 
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Figure 3.2 The most advanced germ cell types at four months post-grafting.  
Donors were categorized based on developmental pattern of spermatogenesis at the time 
of grafting. Donor categories correspond to immature, young and adult (< 4, 4-6, and > 
6 months old, respectively). Histological appearance of testis tissue xenografts was 
scored based on the percentages of seminiferous tubule cross sections with 
degeneration, Histological appearance of testis tissue xenografts was scored based on 
the percentages of seminiferous tubule cross sections with Sertoli cell only or with 
spermatogenesis containing the cells specified as the most advanced germ cell types 
present. 
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Figure 3.3 The most advanced germ cell types at six or eight months post-
grafting.  
Donors were categorized based on developmental pattern of spermatogenesis at the 
time of grafting. Donor categories correspond to immature, young and adult (< 4, 4-6, 
and > 6 months old, respectively). Histological appearance of testis tissue xenografts 
was scored based on the percentages of seminiferous tubule cross sections with Sertoli 
cell only or with spermatogenesis containing the cells specified as the most advanced 
germ cell types present. 
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Figure 3.4 Histological 
appearances of testis tissue 
xenografts at the time of 
grafting, and at four, six or 
eight months post-grafting.  
A, B, C: 2.5 months old 
donor at the time of grafting 
and at four and six months 
post-grafting, respectively. 
D, E, F: 4.5 months old donor 
at the time of grafting and at 
four and eight months post-
grafting, respectively. 
G, H, I: 8 months old donor 
at the time of grafting and at 
four and eight months post-
grafting, respectively.  
Scale bar = 100 µm at 200X 
and 400X magnifications. 
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3.5 Discussion 
Testis tissue xenografting has allowed complete spermatogenesis up to the generation of 
viable sperm from diverse donor species in recipient mice [6, 8, 11-14, 16, 47, 51]. The 
efficiency of spermatogenesis of testis xenografts has, however, been inconsistent in 
different donor species. Spermatogenesis in xenografts has been shown to be comparable 
to intact testis tissue of donor species from pigs and goats [6], while less efficient 
spermatogenesis was observed in testis tissue xenografts from cats, marmoset monkeys, 
and bulls [8-10, 15, 51]. The underlying mechanisms of these species-specific differences 
have not been clearly identified. Successful outcome of testis tissue xenografting and its 
widespread applicability may also pertain to domestic and wild canids.  
The present study provided the first experimental evidence that canine testis tissue can 
undergo complete maturation after xenografting into immunodeficient recipient mice (Fig 
3.2, 3.3, 3.4B, C). Immature canine testis xenografts initiated and maintained complete 
spermatogenesis after grafting. Most notably, immature dog testis tissues exhibited 
considerably greater developmental potential than tissues from older donors over a long 
period of time (Fig 3.4B, C). However, successful testis xenografts exhibited decreased 
sperm production, compared to the same age intact canine testis tissue (Fig 3.1, 3.3).  
Donors were categorized based on developmental pattern of spermatogenesis at the time 
of grafting. Immature, young, and adult categories corresponding to less than four months, 
four to six months and greater than six months of age, respectively, were established for 
statistical analysis. Immature and young dogs were identified as the most promising donor 
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age groups to achieve high graft recovery rate, growth and development. At four months 
post-grafting, immature and young donor xenografts demonstrated markedly higher graft 
recovery rate, graft weight, vesicular gland index, seminiferous tubule number, and 
seminiferous tubule diameter than those of the adult donors. Immature donor xenografts 
also exhibited greater graft weight, vesicular gland index, seminiferous tubule number and 
tubular diameter than those of adult donor xenografts at eight months post-grafting. 
However, the young donors showed variable graft recovery rate (88 ± 4.4 and 56 ± 26.5 at 
four and eight months post-grafting, respectively), growth and development, along with 
less efficient spermatogenesis quantitatively and qualitatively. Lower efficiency of 
spermatogenesis has been reported likely as a result of initial germ cell loss and 
subsequent developmental dysfunction in testis tissues after xenografting [15]. Grafts from 
adult donors, on the other hand, revealed degeneration with only partial maintenance or 
recovery of spermatogenesis in a few instances. Nevertheless, the partial recoveries of 
spermatogenesis in some mature testis tissue xenografts and the development of 
spermatocytes and round spermatids at four and eight months are noteworthy. These 
findings, which are in agreement with previous studies on testis tissue xenografting of 
adult hamsters, horses, cats, and humans, suggest that adult dog testis tissue might not be 
suitable for xenografting [7, 11, 30, 49, 60]. The degenerative tissue response is the 
prominent feature of adult testis tissue xenografting, which may be associated with lower 
tolerance of the tissue to periods of ischemia after xenografting compared to younger 
donors [7]. 
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Immature dog testis tissue grafts showed no differentiation along the seminiferous cords at 
the time of grafting. This group developed varying degrees of normal spermatogenesis up 
to the generation of round and elongated spermatids and also maintained the newly 
established spermatogenesis up to eight months after grafting. Testis tissue xenografts 
from one of the 2.5 months old donors, however, unexpectedly regressed and no 
detectable grafts were found six months post-grafting. The higher efficiency of testis tissue 
xenografts from immature vs. mature dogs is demonstrated by a relatively higher number 
of seminiferous tubule cross sections per harvested graft with more advanced germ cell 
types. The immature littermate donors were consistent in recovery, growth and 
development of round and elongated spermatids at different time-points after grafting. 
Evidence indicates that the resulting spermatogenesis in immature and young testis 
xenografts was clearly not equivalent to intact testis of dogs of a similar age. In the 
immature donors, we expected to observe a higher proportion of seminiferous tubules 
containing elongated spermatids or sperm after six or eight months. In one case, the 
prevalence of elongated spermatids in a 2.5 months old donor at four months post-grafting 
was comparable to intact testis from a seven months old dog, but no further development 
was observed at six months post-grafting. Unfortunately, the prevalence of elongated 
spermatids in all other donor grafts after four or eight months was reduced and not 
comparable to the intact testis tissue of dogs of the same age. 
Young dog donor groups were classified by initiation of spermatogenic development and 
partial differentiation with round spermatids as the most advanced germ cell type at the 
time of grafting. These groups showed no elongated spermatids at the time of grafting. 
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Young testis xenografts had remarkable growth, variable graft recovery rate (88 ± 4.4 and 
56 ± 26.5 at four and eight months post-grafting, respectively) and less efficient 
spermatogenic development up to formation of round and elongated spermatids at the four 
and eight months time frames. A greater graft recovery rate and partial spermatogenic 
development have also been shown in testis tissue xenografts of young horses, donkeys, 
and monkeys, when compared to adult testis tissue xenografts with poor recovery and no 
spermatogenic development [30]. In our study of canine testis tissue xenografting, the 
variation in testis maturation among young groups may be attributed to different breeds or 
donor effect. This finding has been supported by previous reports of testis tissue 
xenografting with other species [11, 15, 109]. Due to these aforementioned studies, 
variations in donor breed may limit our ability to conclusively characterize spermatogenic 
development in immature and young donor grafts.  
Adult donor grafts exhibited partial recovery (0 - 45%) at four months post-grafting. Most 
failed to maintain spermatogenesis and underwent degeneration. Our findings are 
consistent with previous observations that indicate spermatogenesis cannot generally be 
maintained in testis tissue xenografts from adult donors [7, 30]. Nevertheless, we observed 
partial recovery and maintenance of spermatogenesis in a few seminiferous tubules in a 
graft from a 22 months old donor, although spermatogenesis in these tubules only 
advanced as far as the primary spermatocyte stage. This partial recovery of some 
seminiferous tubules along with excessive degeneration and spermatogenic regression has 
also been observed in adult mice and human testis grafts [7, 60]. The chance of partial 
recovery of seminiferous tubules or maintenance of spermatogenesis in both young and 
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adult donor xenografts could be related to the re-establishment of the existing 
spermatogenesis occurring in the intact testes at the time of grafting.  
In this study, we often observed variation between grafts in the same recipient, as well as, 
within-individual grafts. Often there were more differentiated tubules toward the edges of 
the graft than the center of the grafts. Vascularisation deficiencies, as well as, different 
rates of Sertoli cell maturation in various seminiferous tubules, and possible germ cell loss 
after grafting are suggested reasons that may contribute to these variations [11, 15, 109].  
Histological characteristics of the donor testis tissue at the time of grafting appear to be a 
reliable indicator of grafting success. Regardless of the donor species, the more advanced 
spermatogenesis is at the time of grafting, the greater is the chance of degeneration in the 
graft. Poor recovery of adult testis grafts has been suggested to be due to more intense 
spermatogenic activity in adult xenografts at the time of grafting. Possibly, this tissue is 
more sensitive to hypoxic ischemia before vascularisation [7, 30]. It is not known if this 
observation is consistent for all species. The degree of efficient vascularisation which is 
controversial [7, 30, 109] needs to be further defined in grafts of immature and adult testis. 
The inability of Sertoli cells of sexually mature testes to divide may be offered as another 
likely reason for developmental breakdown in adult grafted testis tissues [110]. Our 
current knowledge of testis tissue xenografting does not clearly explain why adult testis 
grafts develop or degenerate, nor does it explain what determines the partial recovery or 
development of these grafts over extended periods of time.  
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Contrary to an earlier study which indicated a positive effect of exogenous gonadotrophin 
treatments on graft growth and maturation [109], our study did not support those 
observations. This illustrates that results of testis tissue xenografting from one species can 
not necessarily be extrapolated to another species. Vesicular gland indices, as indicators 
for production of bioactive testosterone by Leydig cells of the grafts, were evaluated in all 
recipients. As anticipated, mice carrying grafts of immature and young donor tissues had 
higher vesicular gland indices than mice carrying adult donor testis xenografts. This 
indicates that immature and young donor testis xenografts are more responsive to mouse 
gonadotrophins. 
This study was intended to provide information on the developmental potential of dog 
testis tissue from a variety of ages and breeds. However, further research using more 
donors per age group, preferably of the same breed, and a higher number of recipients 
could be beneficial to reduce variability. The development of improved research 
techniques such as testis cell-specific gene expression or germ cell-specific markers could 
improve the ability to track spermatogenic maturation and would be beneficial to attain   
more consistent and reliable outcomes.  
In conclusion, this study demonstrated that xenografting of immature canine testis tissue 
could offer an excellent practical technique for complete ex situ spermatogenesis in the 
recipient mouse. This is the first report of canine testis tissue xenografting with successful 
initiation and maintenance of testis tissue growth and development which produced round 
and elongated spermatids as the most advanced germ cells. Developmental progress in 
testis tissue xenografts from immature donors proved to be successful, although it was less 
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efficient than that of the intact testis tissue of the same age dogs. Testis tissue from young 
dog donors produced variable graft recovery rates, growth, and development of the 
xenografts over time. Although we did not test the functional competence of dog sperm 
from xenografts, xenogeneic sperm have been shown to be fertile in studies of other 
species [6, 8, 12]. Our findings open new possibilities for the preservation of wild life 
male germ-lines, especially of canine species. Most importantly, dog testis tissue 
xenografting provides a feasible in vivo model for exploration of testis function across all 
canids. 
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CHAPTER 4: CRYOPRESERVATION OF IMMATURE PORCINE TESTIS 
TISSUE TO MAINTAIN ITS DEVELOPMENTAL POTENTIAL AS 
XENOGRAFTS  
4.1 Abstract  
The purpose of this study was to develop effective strategies for cooling and 
cryopreservation of immature porcine testis tissue that maintain its developmental 
potential. Testes from one week old piglets were subject to one of twelve 
cooling/cryopreservation protocols: as intact testes, cooling at 4 °C for 24, 48, or 72 hr 
(Experiment 1); or as fragments, programmed slow-freezing with dimethyl sulfoxide 
(DMSO), glycerol, or ethylene glycol (Experiment 2); or solid-surface vitrification using 
DMSO, glycerol, or ethylene glycol, each using 5, 15, or 30 min cryoprotectant exposure 
times (Experiment 3). For testis tissue xenografting, four immunodeficient recipient mice 
were assigned to each protocol, and each mouse received eight grafts. The recipient mice 
were sacrificed four months post-grafting to assess the status of graft development. 
Morphology and in vitro assessment of cell viability showed cooling of testis tissue at 4 
°C for up to 72 hr maintained the structural integrity, cell viability, in vivo growth, and 
developmental potential with spermatogenesis up to formation of elongated spermatids 
and sperm, comparable to fresh tissue (control). In frozen-thawed testis tissues, higher 
numbers of viable cells were present using a programmed slow freezing protocol with 
glycerol as compared to DMSO or ethylene glycol (P < 0.001). Among the vitrified 
groups, the use of DMSO with a 5-min exposure time yielded numerically higher viable 
cell numbers than other groups. Frozen-thawed tissue fragments recovered after 
xenografting showed normal spermatogenesis; germ cells advanced to round and 
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elongated spermatids after programmed slow-freezing using glycerol as well as after 
vitrification using glycerol with 5 or 15 min exposure times or using DMSO with a 5-min 
exposure time. In conclusion, these findings suggest that cooling / cryopreservation and 
xenografting of immature porcine testis tissue offer suitable methods for short-term and 
long-term preservation of testis tissue, which could be used to develop these new 
experimental approaches for restoration of male fertility. 
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4.2 Introduction 
Transplantation of dissociated testis cells [20, 111] and grafting of small fragments of 
testis tissue [6] from a donor into recipient mice are two novel experimental tools with 
potential therapeutic applications for restoring fertility in males. These systems have 
allowed the study and manipulation of different aspects of the dynamic process of 
spermatogenesis, an otherwise seemingly impossible task. However, immediate 
transplantation or grafting of fresh testis cells or tissues is not always possible or desirable. 
Therefore, the ability to preserve donor testis tissue for future use is critical. Testis tissue 
harbours spermatogonial stem cells that exhibit tremendous potential for self-renewal and 
proliferation. Effective preservation of testis tissue may maintain this potential until the 
tissue is allowed to resume its development.  
Although cryopreservation of isolated testis cells has been successfully achieved for 
animals and humans [80, 106, 112, 113], so far very little attention has been paid to 
cryopreservation techniques aimed at maintaining the developmental potential of 
structurally intact testis tissue. Cryopreservation of testis tissue theoretically offers a 
practical method when other techniques such as cryopreservation of ejaculated sperm [59] 
are not available or applicable. Preservation of testis tissue has many applications, 
including salvaging the genetic potential of immature endangered and valuable animals or 
conservation of fertility for pre-pubertal boys undergoing gonadotoxic cancer therapies. 
To our knowledge, no cryopreservation protocol specifically designed for immature testis 
tissue can offer preservation of functional competence and cellular viability of testis 
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needed for such applications. Several studies have examined cryopreservation of testis cell 
suspensions or tissue fragments using glycerol, ethylene glycol, DMSO, or propanediol 
[114-116], but lack any functional assessment of spermatogenic cells. However, even if 
many cells of a multicellular system survive freezing and thawing, preservation of all 
functional compartments of the tissue is not guaranteed [82]. Furthermore, no report has 
characterized or provided a vitrification technique for immature testis tissue capable of 
maintaining the potential of the tissue for completion of spermatogenesis. Merely 
maintaining the physical characteristics of the cryopreserved testis tissue is not adequate; 
an efficient approach to overcome the deficiencies in developmental (re)establishment of 
spermatogenesis is also required. 
This study was designed to develop and compare a number of strategies for cooling or 
cryopreservation of porcine testis tissue that both minimize damage to the tissue and 
maintain its developmental potential. Damage to the tissue was determined by an in vitro 
assessment of cell viability. Development potential was evaluated through a histological 
examination of testis tissue grafted under the back skin of immunodeficient recipient mice. 
4.3 Materials and methods 
4.3.1 Study design 
Immature porcine testes were subject to one of twelve cooling/cryopreservation protocols: 
cooled at 4 ºC for 24, 48, or 72 hr as intact testes (Experiment 1); or cut into 5 mg testis 
tissue fragments and cryopreserved using programmed slow-freezing with DMSO, 
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glycerol, or ethylene glycol (Experiment 2); or subjected to solid-surface vitrification with 
sucrose, ethylene glycol, and either DMSO or glycerol (Experiment 3). We also examined 
the effects of using larger diameters of tissue fragments (15, 20, or 30-mg) on 
cryopreservation outcome. Cooled and frozen-thawed tissues were assessed for in vitro 
cell viability and developmental potential after xenografting into recipient mice. Half of 
the recipient mice were treated with exogenous gonadotrophins to examine whether such 
treatments enhanced the xenografting outcome. Recipient mice were sacrificed at four 
months post-grafting to assess the efficiency of xenografting and the status of 
spermatogenesis in the xenografts. 
4.3.2 Preparation of donor testis tissue 
Donor testes were obtained from a university-affiliated swine facility after routine 
castration of Yorkshire-cross piglets (< 1 week old). Testes were shipped to the lab within 
1 hr of collection in Dulbecco‟s phosphate buffered saline without calcium and 
magnesium (DPBS, Cat# 20-031- CV; Mediatech, Herndon, VA) on ice. The testes were 
then rinsed three times in DPBS and underwent cooling or were decapsulated, with the 
parenchyma cut into 5-mg fragments and maintained in Dulbecco‟s modified Eagle‟s 
medium (DMEM, Cat# 50-003-PB; Mediatech) on ice for 1-2 hr until use in slow freezing 
or vitrification procedures. A subset of testis tissues were also cut into larger fragments 
(15, 20, and 30 mg) in the shape of strips. Comparable tissue fragments were fixed before 
and after equilibration in cryoprotectants, as well as after freezing- thawing, as reference 
for histological examination of tissue integrity and development. 
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4.3.3 Preservation of testis tissue 
Experiment 1- Refrigeration: Intact testes (enclosed within the tunica albuginea) were 
stored in DPBS at 4 ºC for 24, 48, or 72 hr. 
Experiment 2- Programmed slow-freezing: Fragments of testis tissue (5, 15, 20, or 30 mg 
each) were equilibrated in different freezing media with varying concentrations of 
cryoprotectants comprising: 1. DMEM + 5% fetal bovine serum (FBS, Cat# 26400-036, 
Gibco, Carlsbad, CA) + 10% dimethyl sulfoxide (DMSO, Cat# 210002, BioVeris, 
Gaithersburg, PA); 2. DMEM + 5% FBS + 7% glycerol (Cat# G2025, Sigma, St. Louis, 
MO); 3. DMEM + 5% FBS + 7% ethylene glycol (Cat# 102466, Sigma) + 0.1 M/L 
sucrose (Cat# S1888, Sigma). Testis tissue fragments along with 0.45 mL of the freezing 
medium were packaged into 0.5-mL plastic mini-straws at room temperature (one testis 
tissue fragment per straw). Straws were sealed and loaded into a programmable freezer 
(IceCube 14S, Cat# 16821/2000, Minitube, Ingersoll, ON, Canada) and underwent a 
defined freezing program. Sample and chamber temperatures were monitored during the 
entire freezing process by inserting a thermocouple in one of the straws and one placed in 
the chamber. The freezing program was developed and modified based on a previous 
report on human testis tissue cryopreservation [115]. The process was initiated by 
maintaining the straws at 22 ºC for 10 min, cooling to 4 ºC at -1 ºC/min, holding at 4 ºC 
for 5 min, cooling at 0.3 ºC/min from 4 ºC to -8 ºC, holding at -8 ºC for 10 min, cooling at 
0.5 ºC/min from -8 ºC to -50 ºC, then 10 ºC/min from -50 ºC to -90 ºC, and holding for 10 
min at -90 ºC. At this point, straws were plunged directly into liquid nitrogen (LN2) and 
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stored until analysis. The freezing program was similar for the three freezing media as 
described above, and no seeding was applied in these protocols. 
Experiment 3 - Solid-surface vitrification: Groups of 5-mg testis tissue fragments were 
equilibrated in either DMSO-vitrification solution 1 (DMSO-VS1; DMEM + 7.5% DMSO 
+ 7.5% ethylene glycol; v/v) or glycerol-vitrification solution 1 (glycerol-VS1; DMEM + 
3.5% glycerol + 7.5% ethylene glycol; v/v) at 22 ºC for 10 min. To evaluate the effects of 
exposure time to the vitrification solutions, tissue fragments were then exposed for 5, 15, 
or 30 min to either DMSO vitrification solution 2 (DMSO–VS2; DMEM + 20% v/v FBS 
+ 15% v/v DMSO + 15% v/v ethylene glycol + 0.5 M sucrose) or glycerol-vitrification 
solution 2 (glycerol–VS2, DMEM + 20% v/v FBS + 7% v/v glycerol + 15% v/v ethylene 
glycol + 0.5 M sucrose), respectively (Fig. 4.1A). The tissues were then immediately 
transferred onto aluminum boats floating on LN2 using very fine forceps  (Fig. 4.1B) to 
minimize the carryover of medium drops around the tissues [117]. After vitrification, three 
pieces of tissue were transferred into each cooled cryovial (Cat# 5012-0020, Nalgene 
Nunc, Northbrook, IL) floating on LN2 (Fig. 4.1C). Cryovials were immediately plunged 
and stored in LN2 until evaluation or xenografting. 
4.3.4 Thawing process 
Cryopreserved testis tissue fragments were thawed using one of the following procedures: 
1) Straws containing cryopreserved tissues using programmed slow-freezing were 
transferred from the LN2 tanks and immersed into a water bath (37 ºC) until the ice melted 
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(~11 sec). The sealed end of the straws were cut and the tissues drained into 2 mL of the 
first thawing solution (DMEM + 20% v/v FBS + 0.5 M sucrose) at 37 ºC and incubated 
for 1 min. The tissues were then washed in the second solution (DMEM + 20% v/v FBS) 
at 37 ºC for 1-2 min and kept in this medium on ice until immediate examination or 
xenografting. After thawing, the larger tissue fragments (15, 20, or 30-mg) were cut into 
5-mg fragments prior to in vitro and in vivo analyses. 
2) Cryovials containing vitrified tissues were removed from the LN2 tank and kept at room 
temperature for about 30 sec. The cryovials were then filled with the thawing solution 
(DMEM + 20% FBS v/v + 0.5 M sucrose) and the tissues transferred into the same 
thawing solution at 37ºC for 1-2 min. The tissues were then washed in DMEM + 20% v/v 
FBS at 37 ºC for 1-2 min and kept in the same solution on ice until further assessment or 
immediate xenografting. 
4.3.5 In vitro assessment of cell viability 
Fresh (control) cooled and frozen-thawed testis tissues underwent a sequential enzymatic 
digestion [6, 118, 119] to investigate the extent to which the preservation techniques 
affected cell viability. Briefly, we used 0.2% w/v collagenase type IV (Cat# C5138, 
Sigma) in DMEM at 37 ºC for 8 to 10 min with occasional agitation, followed by the 
addition of 0.1% w/v hyaluronidase (Cat# H3884, Sigma) in DMEM for 15-20 min, and 
0.01% w/v DNase type I (Cat# DN-25-IG, Sigma) in DMEM for an additional 5-10 min. 
After centrifugation at 500 g and removal of supernatant, the resulting cell pellet was 
resuspended in 0.25% w/v trypsin with 2.21 mM EDTA (Cat# MT-25-053-CI, 
  
 
80 
 
Mediatech), and the trypsin reaction stopped by the addition of an equal volume of FBS 
(equal to the total volume). To calculate the resultant cell concentration and viability, 50 
μL of trypan blue (0.4% solution Cat# T8154, Sigma) was added to 50 μL of the cell 
suspension, a sample of which was placed on a haemocytometer and observed under a 
bright-field microscope (at 400X magnifications). Tissue digestions and in vitro cell 
viability assessments were performed in triplicate. 
4.3.6 Xenografting of testis tissue fragments into immunodeficient mice 
The developmental competence of the fresh (control) and preserved testis tissue fragments 
was assessed by grafting under the back skin of recipient mice as previously described [6]. 
All animal experiments were approved by and performed under the guidance of the 
University of Saskatchewan Animal Care and Use Committee. Male immunodeficient 
mice (nu/nu NCr nude, Taconic, NY) about 8 week old were anaesthetised using intra-
peritoneal injection of a mixture of ketamine hydrochloride (100 mg/kg; Ketalene, 
Bimeda-MTC, Cambridge, ON, Canada) and xylazine hydrochloride (10 mg/kg; Vet-A-
Mix, Shenandoah, IA). Throughout the study, the mice were housed in microisolator cages 
in groups of four, maintained under controlled photoperiod (lights-on 6 a.m. through 6 
p.m.) and handled aseptically with sterile water and mouse chow provided ad libitum. 
After surgical preparations, the mice were castrated and grafted with eight testis tissue 
fragments (about 5 mg each) subcutaneously on their back skin. The incision sites were 
closed using wound clips (Michel Clips 7.5 mm, Miltex, York, PA). Groups of mice 
received fresh (control) and cooled/cryopreserved testis tissue fragments preserved by 
different protocols (2 grafts / protocol / mouse, 4 mice/group, n = 28) as follows: Group 1: 
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Fresh and cooled tissues for 24, 48, or 72 hr; Group 2: Fresh and frozen tissues with 
programmed slow-freezing protocols using DMSO, glycerol, and ethylene glycol, with 
fragments that were 5 mg each throughout the preparation; Groups 3, 4, 5: Same as the 
previous group but using fragments that were originally 15, 20, or 30 mg each, 
respectively; Group 6: Fresh and vitrified tissues using DMSO after 5, 15, or 30 min of 
cryoprotectant exposure time; Group 7: Fresh and vitrified tissues using glycerol after 5, 
15, or 30 min of exposure time. 
The effects of exogenous gonadotrophins on development of xenografts were investigated 
by treating half of the mice in each group with equine chorionic gonadotrophin (eCG, 
Folligon, Intervet, Whitby, ON, Canada) and human chorionic gonadotrophin (hCG, 
Chorulon, Intervet) twice a week (s.c., 10 IU each hormone), starting immediately after 
xenografting and continuing until sacrifice at 4 months post-grafting. 
4.3.7 Analysis of xenografts 
At 4 months post-grafting, mice were anesthetised and sacrificed after cervical dislocation. 
The mice were weighed, the back skin dissected open and photographed, and the number 
of detectable grafts recorded. After dissection from the skin, grafts were weighed and 
fixed in Bouin‟s solution for 24 hr followed by rinsing with and storage in 70% ethanol 
until processing for histological analysis.  
Histological slices (7 μm) were prepared from the largest diameter of the grafts and 
stained with haematoxylin and eosin. Histological analyses were performed using a 
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microscope equipped for digital photomicrography (Northern Eclipse Image Analysis 
software, version 7.0, Empix, Mississauga, ON, Canada). Analyses included assessing 
tissue integrity, counting the number and measuring the diameter of all seminiferous 
tubules in the slide, and scoring each tubular cross-section according to a previously used 
scale [7, 14] by characterizing the incidence of the most advanced germ cell types present 
in each tubule cross section. The operator was blinded to the source of the grafts to be 
analyzed. Each seminiferous tubule was scored as: (i) complete tubular degeneration and / 
or fibrosis and / or Sertoli cell only tubules; (ii) gonocytes or spermatogonia as the only 
type of germ cells; (iii) primary or secondary spermatocytes as the most advanced germ 
cells; (iv) round spermatids as the most advanced germ cells; (v) elongated spermatids as 
the most advanced germ cells; or (vi) mature sperm present in the lumen of the tubule. 
4.3.8 Statistical analyses 
The effects of refrigeration time (Experiment 1), different cryoprotectants in slow-freezing 
(Experiment 2), as well as different vitrification media and exposure times to these media 
(Experiment 3) were analyzed using one-way or two-way ANOVA with the Holm-Sidak 
test as post-ANOVA analysis. Data without a normal distribution were assessed using the 
non-parametric Kruskal-Wallis ANOVA on ranks with Dunn's test. Spearman's 
correlation coefficient was determined between the weight of the recovered grafts and 
seminiferous tubule numbers or diameters. Statistical analyses were performed using 
SigmaStat (version 3.5, Systat, Chicago, IL) and P < 0.05 was used as the level of 
statistical significance. Average values were expressed as mean ± SEM. One mouse died 
prior to the time of analysis and was excluded from the data. 
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4.4 Results 
4.4.1 In vitro assessment of cell viability 
The effects of cooling and cryopreservation on cell viability, growth, and developmental 
potential are summarized in Tables 4.1 and 4.2. 
Experiment 1: Intact (uncut) testes cooled at 4 ºC for 24, 48, or 72 hr retained very high 
cell viability after storage, comparable to fresh control tissue, with no significant reduction 
in the number of viable cells during the length of cooling (P = 0.74; Table 4.1). 
Experiment 2: Cell viability (%) was not affected by the original size of the testis tissue 
fragment (5, 15, 20, and 30 mg) undergoing the same cryopreservation treatment (P = 
0.32), and therefore the data were pooled for all further analyses. Cell viability of testis 
tissues cryopreserved via programmed slow-freezing was higher (P < 0.001) with 
glycerol-based freezing medium (88 ± 3.3%) compared to DMSO-based (75 ± 7.8%) and 
ethylene glycol-based (55 ± 11.5%) freezing media. In addition, significantly more cells 
(by about 5-fold) were isolated from the programmed slow frozen tissues using glycerol-
based medium (P < 0.001) than from DMSO- or ethylene glycol- based media (Table 4.2). 
Experiment 3: The vitrified tissue showed no significant effect of cryoprotectant exposure 
times (5, 15, or 30 min) for either of the cryoprotectants (P = 0.22). The interaction of 
equilibration time and cryoprotectant did not affect the number or percentage of viable 
cells in testis tissues (P = 0.27). However, a numerically higher cell viability (%) and 
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number was evident in vitrified tissues equilibrated in DMSO for 5 min as compared to 
the other treatments. 
4.4.2 Assessment of testis tissue xenografting 
Histological analysis was performed at four time points: on fresh tissue before any 
manipulations; after incubation in different cryoprotective agents; and after freezing-
thawing procedures but prior to grafting or viability assessment; and at four months after 
xenografting into mice. The structural integrity of all cooled and cryopreserved tissues 
appeared comparable to fresh testis tissue, and no histological damage was evident under 
light microscopy after cryoprotective exposure or after freezing-thawing. Exogenous 
gonadotrophin treatment of the recipient mice did not affect the recovery and development 
of xenografts (P = 0.90), and therefore the data from treated and non-treated mice were 
pooled. 
Experiment 1: Pre-grafting storage of intact testes at 4 ºC for 24, 48, or 72 hr did not 
significantly alter the recovered graft weight (P = 0.18) or the number of seminiferous 
tubules (P = 0.49), as compared to fresh (control) tissues. However, the diameter of 
seminiferous tubules significantly differed between the fresh and cooled tissue xenografts 
(P < 0.001; Table 4.1). No significant relationship was evident between the number of 
seminiferous tubules and the weight of the corresponding grafts (P > 0.05). 
Experiment 2: Pre-grafting cryopreservation of testis tissue fragments using programmed 
slow freezing with DMSO or ethylene glycol resulted in a low graft weight (after 4 
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months, the grafts were still comparable in weight to the testis tissue fragments at the time 
of grafting) and a low recovery rate, and consequently grafts contained very few 
seminiferous tubules (Table 4.2). These groups were consequently excluded from further 
statistical analyses to avoid imbalanced comparisons. Growth of testis tissue grafts was 
not affected by the original size of the testis tissue fragments (5, 15, 20, and 30 mg; P = 
0.32), and therefore these data were pooled. 
Programmed slow-freezing using glycerol caused no significant changes in the graft 
weight (P = 0.19) or seminiferous tubule number (P = 0.76) compared to fresh controls, 
but seminiferous tubule diameters were smaller than in fresh (control) grafts (P < 0.001; 
Table 4.2). 
Experiment 3: Tissues vitrified in glycerol-VS2 using 5- and 15-min exposure time and 
fresh testis tissue xenografts were not significantly different with respect to graft weight (P 
= 0.35) or number of seminiferous tubules in the recovered grafts (P = 0.13). However, the 
5-min exposure time in glycerol-VS2 provided better protection to testis tissues against 
freezing damage than 15- or 30-min exposure times, as evidenced by significantly larger 
seminiferous tubule diameters in recovered grafts (P < 0.001). The seminiferous tubule 
diameters from the DMSO-VS2 5-min exposure time group were comparable to grafts of 
fresh tissues (121 ± 1.8 vs. 130 ± 5.9 μm, respectively; P = 0.05) and significantly higher 
than tissues exposed to DMSO-VS2 for 15 min (P = 0.009). No grafts were recovered 
from tissues exposed to DMSO-VS2 for 30 min (Table 4.2). Due to the small number of 
recovered grafts, the impact of different cryoprotectants on vitrified graft weight and 
seminiferous tubule number was not considered in further statistical analyses. 
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4.4.3 Assessment of spermatogenic development after xenografting 
Prior to grafting, the donor testis tissue contained seminiferous cords with gonocytes / 
spermatogonia as the only germ cell type present (Fig. 4.2A). 
Experiment 1: Regardless of the pre-grafting storage duration at 4 ºC, complete 
spermatogenesis with elongated spermatids was the most advanced germ cell development 
observed in testis tissue grafts in all groups at four months post-grafting (Fig. 4.3). 
Experiment 2: At four months post-grafting, no differences in developmental status of the 
tissue were observed between testis tissue grafts of originally different sizes (5, 15, 20, and 
30 mg, P > 0.05), and therefore the data were pooled. Complete differentiation of 
spermatogenic cells was observed in grafts from the group of testis tissues frozen using 
programmed slow-freezing with glycerol (Fig. 4.2F and 4.4A). However, few grafts and 
seminiferous tubules survived the programmed slow-freezing with DMSO or ethylene 
glycol. Only three out of 32 grafts survived in the groups of testis tissues cryopreserved 
with DMSO and no graft survived in the ethylene glycol group. These groups were 
therefore excluded from statistical analyses. 
Experiment 3: Histological assessment indicated that vitrification in glycerol VS2 with 5- 
and 15-min exposure times or DMSO-VS2 with a 5-min exposure time more effectively 
preserve the developmental potential of testis tissues. Recovered grafts had elongated 
spermatids as the most advanced germ cell types present, which was comparable to grafts 
from fresh (control) tissue (Fig. 4.2C, D, E and 4.4B). 
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4.5 Discussion 
Despite its potential importance, little attention has been paid to developing and evaluating 
workable protocols for slow-freezing and vitrification of immature testis tissue with 
evidence of functional restoration. We used a number of strategies to preserve immature 
testis tissues and to evaluate preservation effects on the tissues, including xenografting 
preserved testis tissue into recipient mice. Testis tissue xenografting into immunodeficient 
recipient mice has been used as a unique approach to achieve testis tissue maturation and 
complete spermatogenesis from fresh immature testis tissue from a donor species [6-13]. 
Grafting of frozen-thawed testis tissues has also been demonstrated [6, 16, 25, 120], albeit 
with low efficiency and without a critical evaluation of different preservation strategies. 
This study provided strong evidence that 24, 48, and even 72 hr storage of intact testes at 4 
ºC does not impair the structural integrity, survival, or proliferative potential of immature 
porcine testis tissue. This has practical implications as shipment of testes to other labs for 
cryopreservation or xenografting may take more than a day. Our results generally concur 
with an earlier study in which non-human primate testis tissues were cooled for 24 hr prior 
to grafting, then analyzed at 12 weeks post-grafting [120]. However, our results show a far 
higher graft survival rate and 10-30 fold greater graft weights at 4 months post-grafting. 
Moreover, we demonstrated that cell viability, graft survival, and developmental 
competence of tissues cooled for 24, 48, or 72 hr were comparable to fresh (control) testis 
tissue. Interestingly, we found a higher percentage of seminiferous tubules with more 
advanced germ cell types in tissues cooled for 48 or 72 hr than in fresh or 24 hr cooled 
testes. We speculate these results may collectively indicate that the developmental 
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potential of testis tissue is positively impacted by low but stable metabolism prior to 
grafting; proper cooling may help the graft acclimate to the hypoxic conditions that 
probably exist immediately after xenografting and therefore improve subsequent 
development. 
Nine different cryopreservation strategies were compared to evaluate the impact of 
freezing rate (slow vs. ultrafast), cryoprotectants, and length of exposure to 
cryopreservative agent (CPA) on testis tissue. Slow controlled freezing with glycerol has 
been in common use for embryo preservation since the 1980‟s [121]; however, applying 
the same cryopreservation conditions for tissues is more challenging because the 
cryopreservation protocol must be modified for all different cell types present in the tissue. 
With respect to slow-freezing, cryopreservation of testis tissue with glycerol showed 
higher (~88%) post-thaw cell survival than with DMSO or ethylene glycol. Cell viability 
was comparable to cooled or even fresh tissues. This finding is in contrast to a recent 
report by Milazzo et al. (2008) showing high cell viability (~90%) with programmed slow-
freezing of immature mouse testis tissue using DMSO as a cryoprotectant [122]. Keros et 
al. (2005) have also shown harmful effects of glycerol on testis tissue of human adult 
patients [115]. They suggest that DMSO was a suitable cryoprotectant for testis tissue, 
based on morphological assessment, ultra-structural data, and in vitro testosterone 
production after cryopreservation. DMSO has also been found to be a more suitable 
cryoprotective agent than ethylene glycol for immature mouse, rat, and non-human 
primate testis tissue [123-125]. DMSO has been effectively employed for cryopreservation 
of immature mouse testis tissue [7, 16, 126, 127], with no morphological changes to the 
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testis tissue and with maintenance of functional Leydig cells [115]. Shinohara et al. (2002) 
reported the birth of mouse offspring from sperm retrieved from cryopreserved pre-
pubertal testis tissue with DMSO after transplantation under tunica albuginea of the 
recipient testes [16]. Species differences could account for differences between our results 
and these earlier observations as cryopreservation protocols are cell, tissue and organ 
species-specific. Glycerol has a strong affinity for the cellular phospholipid head groups 
during freezing [34], buffers salts at low temperatures, binds with metallic ions, 
dehydrates cells, and reduces ice expansion during water solidification [128, 129]. High 
cryoprotection of glycerol observed in our study, may have been associated with the slow-
freezing protocol we employed. This technique could therefore offer a reliable 
cryopreservation technique for maintenance of the potential of immature porcine testis 
tissue for complete maturation and spermatogenesis. We also observed higher graft 
survival, weight, and seminiferous tubule number with complete spermatogenesis in testis 
tissue grafts preserved using programmed slow-freezing with glycerol compared to 
DMSO or ethylene glycol. Damage, if any, was possibly minimized due to the well-
defined osmolality control (solution effect) and a limited concentration of glycerol to 
avoid the toxic effect of glycerol-based solutions [81, 82]. Our programmed slow-freezing 
protocol using DMSO or ethylene glycol did not offer promising results, which could be 
attributed to the long exposure time. Due to their lower molecular weights, DMSO and 
ethylene glycol have higher penetration rates than glycerol, and thus prolonged exposure 
can cause toxicity leading to the inferior graft recovery rate and growth. 
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We also developed a vitrification protocol for cryopreservation of immature testis tissue. 
In vitrification, ice crystal formation is by-passed by using higher concentration of 
cryoprotectants (5M) and an ultrafast cooling rate. As the cryoprotectants have toxic 
effects, vitrification of cells or tissues should be conducted with minimum exposure time. 
In the present study, we focused on the type of cryoprotectant and the most effective 
exposure times to vitrification solutions. Our graft survival and recovered graft weight 
data strongly suggest that protocols of 5 or 15 min in glycerol-VS2 or 5 min in DMSO-
VS2 are preferred for immature testis tissue. The poor graft survival observed when longer 
CPA exposure times of 15 and 30 min in DMSO-VS2 were used was likely due to toxic 
effects of high concentrations of this permeable cryoprotectant on the testis tissue [117]. 
Moreover, histological examination of the recovered grafts from the groups of tissues 
vitrified by 5 or 15 min exposure times to glycerol-VS2 showed a high proportion of 
round spermatids; however, the number of elongated spermatids was 20-fold higher in the 
5-min exposure time group. The absence of surviving grafts from the tissues exposed to 
glycerol-VS2 for 30 min may also be due to the longer exposure time and subsequent 
glycerol toxicity [117]. 
Vitrification requires careful handling of the tissue and an appropriate choice of final 
cryoprotectant exposure [130]. However, this process could provide preferential 
conditions for freezing with superior results in restoration of immature testis tissue. In our 
protocols, ultrafast freezing of the tissue aqueous milieu into a non-crystalline glassy 
phase was achieved by exposing testis tissues to highly viscous solutions of 
cryoprotectants, and ultrafast cooling via placement on a super-cooled aluminum surface 
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(-194.9 °C). This strategy maintains all tissue compartments in a vitreous state [117, 131, 
132] under desirable aseptic conditions; direct plunging of the tissues into liquid nitrogen, 
a commonly used procedure, poses a greater risk of contamination. The solid-surface 
vitrification of testis tissue, as applied in our study, is an easy, safe, and applicable 
cryopreservation technique for the preservation of tissue structural integrity and 
developmental potential. 
To our knowledge, this is the first report of immature testis tissue vitrification showing 
maintenance of cell viability and developmental potential to actively (re)establish 
complete spermatogenesis after xenografting into immunodeficient mice. Interestingly, 
similar post-thaw cell survival rates were observed for the two suitable cryopreservation 
protocols: programmed slow freezing with glycerol and vitrification following 5-min 
exposure time to DMSO-VS2. Additionally, our results confirm in vitro cell viability 
assessment of cryopreserved tissue could be used as a relatively reliable assay to predict 
testis tissue potential for development. 
Reversible suspension of testis tissue growth, development, and spermatogenesis is a topic 
of interest for fertility preservation of immature individuals especially when immediate 
transplantation or xenografting of testis cells or tissues are not applicable. Although the 
effects of cryoprotectant concentration and cooling rate are not similar in all tissues [133] 
or species, our findings offer a number of strategies that can be used to effectively 
cryopreserve immature porcine testis tissue as a model for other species. Restoring the 
developmental potential of immature porcine testis tissue after programmed slow 
cryopreservation and solid-surface vitrification may prove useful in clinical and 
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experimental applications of tissue/gonadal banking. Cryopreservation of testis tissue 
obtained by biopsy is a possible choice for human adults whose only source of sperm is 
the testis parenchyma, especially when combined with sperm detection in frozen-thawed 
cell suspensions of testis tissues for ICSI [134]. But more importantly, cryopreservation of 
immature testis biopsies can offer a unique alternative for prepubertal boys undergoing 
gonadotoxic cancer treatments whose only potential source of spermatogenesis, such as 
spermatogonial stem cells, is at risk. 
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(B) 
(A) 
(C) 
Figure 4.1 Testis tissue vitrification procedures. After exposure of testis tissue 
fragments to vitrification solutions for different lengths of time (5, 15 or 30 min) (A) 
testis tissue fragments were placed on aluminum boats (B) floating on liquid 
nitrogen, then transferred into cooled cryovials (C) followed by plunging into liquid 
nitrogen.  
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Table 4.1 In vitro viability of testis tissue cooled at 4 ºC for 24, 48 or 72 hr before grafting and in vivo developmental competence 
at four months post-grafting. 
 
  
 
                                                                             Fresh (Control)                       24 hr at 4 ºC                              48 hr at 4 ºC                       72 hr at 4 ºC 
       No. of viable cells × 10
3
 per                             3868 ± 790
 a
                             3935 ± 236
 a
                                3878 ± 435
 a
                        3077 ± 823
 a
 
       5 mg  tissue 
       Cell viability (%)                                              92.7 ± 2.2
 a
                               95.4 ± 0.3
 a  
                                 92.8 ± 1.7
 a
                         86.9 ± 4.3
 a 
        Recovered grafts
 
(%)                                             100                                        87.5                                            87.5                                       100 
        Graft weight (mg)                                          129 ± 58.5
 a
                              109.2 ± 40
 a
                                  321 ± 116.7
 b
                       294.5 ± 81.7
 b
 
        No. of seminiferous tubule 
 
                          377 ± 159
a  
                              582 ± 107
 a  
                                 951 ± 332
 a  
                        890.5 ± 175
 a 
        cross sections per graft 
        Seminiferous tubule diameters (µm)
                
108.7 ± 0.84
a
                            101.7 ± 0.86
b   
                              104.8 ± 1.01
c   
                    116.3 ± 0.84
d
 
Number and percentage of viable cells were determined per 5 mg of tissue fragments. Histological attributes were also determined in 
cooled testis tissue xenografts at 4 months post-grafting by the number of seminiferous tubule cross sections per graft and 
seminiferous tubule diameter. Graft recovery rate was defined as the percentage of detectable grafts collected at the time of sacrifice.  
Means with different superscript letters within rows are significantly different (P < 0.05). Data are presented as Mean ± SEM. 
 
9
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Table 4.2 In vitro viability of cryopreserved testis tissue before grafting and in vivo developmental competence at four months 
post-grafting. 
Programmed slow freezing                                                                              Vitrification 
 
                                    DMSO        Glycerol       Ethylene glycol                                DMSO                                                Glycerol 
                                                                                                                                      5 min                15 min              30 min                5 min                15 min          30 min 
 
No. viable cell                    453±120
b  
         2,539±363
a
        395±197
b
                  1,645±494
a            
830±149
b 
        988 ±212
b
         955±256
b                
785±112
b                
1,044±171
b
 
(in 5 mg) × 10
3
 
Viability(%)
 
                     74.8±7.8            88.4±3.3             55.3±11.5                  80±9.9                66.2±5.1         60.4±14            77.7±6.3              61.4±7.9            72.2±8.9 
Recovered  grafts(%)  
        
6.25                      40.6                      N/A                          50                      12.5                N/A                   66.6                     50                       16.6 
Graft weight (mg)            4.5±1.5             91.1±34.6                 N/A                       19.5±9.5              30±0                N/A                 55.5±30.5          179.5±116.5          40±0 
No. of seminiferous          17±0                 363±104.3                3±0                       109.5±30.5          43±0                N/A                 128±58               495±301               183±0 
tubule  cross sections  
per graft 
Seminiferous tubule        70.3±2.8           94.5±1.0              149.5±24.4                120.5±1.8            94.9±4.5           N/A                136.5±3.7           73.3±1.9              86.4±2.6
 
(µm)
1,2 
diameter 
Number and percentage of viable cells were determined per 5 mg of tissue fragments. Graft recovery was defined by the number and weight 
of detectable grafts collected at the time of sacrifice. Histological attributes were also defined by number of seminiferous tubule cross 
sections per largest mid section of recovered graft and tubule diameter at 4 months post-grafting.  
Means with different superscript letters within rows are significantly different (P < 0.05). Data are presented as Mean ± SEM. 
 
9
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Figure 4.2 Histological appearances of fresh and cryopreserved immature porcine testis tissues 
before and four month post-grafting into recipient mice. Fresh immature porcine testis tissue at the 
time of grafting (A); and testis tissue xenografts recovered at four months post-grafting from fresh 
(control) (B); vitrified by exposure to glycerol-vitrification solution 2 (VS2) for 5 min (C); vitrified by 
exposure to glycerol-VS2 for 15 min (D); vitrified after exposure to DMSO-VS2 for 5 min. The inset 
shows presence of sperm in lumen of seminiferous tubule (at 1000X magnification) (E); or cryopreserved 
using programmed slow freezing in glycerol (F). Scale bar = 50 µm at 400X. 
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      Fresh                    
Figure 4.3 The most advanced germ cell types present in the seminiferous tubules of 
fresh or cooled testis tissue. Relative abundance (%) of the most advanced germ cell types 
present in the seminiferous tubules of recovered testis tissue grafts at four months post-
grafting from fresh (control) and cooled testis tissue grafts (at 4 ºC for 24, 48 or 72 hr). 
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Figure 4.4 The most advanced germ cell types present in the seminiferous tubules of fresh 
or cryopreserved testis tissue. Relative abundance (%) of the most advanced germ cell types 
present in the seminiferous tubules of recovered grafts from fresh (control) or cryopreserved 
testis tissue using programmed slow freezing with glycerol (A), or vitrification in DMSO (5 min 
exposure time) or glycerol (5 or 15 min exposure time) (B).  
(B) 
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CHAPTER 5: GENERAL DISCUSSION AND CONCLUSIONS 
The experiments presented in this thesis are pilot studies to advance research on 
preservation of gonadal tissue. We examined the (re)establishment of spermatogenic 
activity of donor testis tissue in different donor age groups of a canine model after testis 
tissue xenografting, and preservation of immature testis tissue using short-term cooling, 
programmed slow freezing or vitrification procedures in the porcine model.  
Despite the wide range of species that have been used as donors for testis tissue 
xenografting, there were no reports of studies using dogs as the donor animal. Canine 
species are excellent models for many scientific and practical applications. Development 
of canine testis tissue xenografting will provide a new insight into the study and 
manipulation of canid testis function in an accessible mouse model. This technique may be 
used to investigate the in vivo potential of testis tissue in (re)establishment of 
spermatogenesis in xenografts. It could also be an alternative to selective breeding of dogs 
to promote genetic diversity in canine population. The selective breeding might produce 
modern breeds with specific physical characteristics, which has put some purebred breeds 
in danger by increasing the risk of genetic, physical or behavioural problems. More 
importantly, testis tissue xenografting may also provide a previously unavailable tool to 
produce gametes from prepubertal males as an alternative to the more challenging 
approach of cloning. This may also improve the possibility of preserving the genetic 
potential of canids that undergo castration before the age of maturity. Preservation of 
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genetic material is crucial for conservation of rare animal breeds or lines. The loss of 
genetic diversity associated with infertility or premature death of valuable species is also a 
major ongoing problem in wild life conservation. Current attempts to address this problem 
through assisted reproduction involve the collection of sperm or ova from the valuable 
animals, before or after death. These attempts have several limitations. The most 
important concern relates to the collection of sperm from males that die before reaching 
sexual maturity. Testis tissue xenografting is a process to salvage genetic potential from 
neonate who may never reach maturity. Testis tissue xenografting will also offer a suitable 
approach to cope with the biodiversity crisis by allowing the movement of genetic 
material, particularly in wild life canine species which are limited by environmental or 
geographical barriers. Xenografting is a leading edge technique that provides millions of 
genetically unique sperm produced in a graft, enabling sperm banks to provide widespread 
diversity in endangered species. Furthermore, there are several genetic diseases which 
involve similar genes in both canine and human species. Therefore, successful 
xenografting of dog testis tissue might open new opportunities to study and address human 
genetic fertility issues.  
We also examined the effect of donor age on progression of spermatogenesis in dog testis 
tissue by xenografting into recipient mice. In this study, complete testis tissue 
development with the generation of elongated spermatids was achieved in immature and 
some young dog testis tissue xenografts. The newly established spermatogenesis was 
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maintained for four, six and eight months after grafting. Our findings confirm that the 
developmental stage of testis tissue at the time of grafting could be a critical factor 
affecting the progressive growth and development of xenografts. Although the reason is 
not well understood, similar studies in other species also indicate that neonatal and 
immature testis tissue xenografts have the ability to achieve efficient maturation and 
complete spermatogenesis in recipient mice. Testis tissue xenografting has also shown 
successful development of spermatogenesis in several species including immature: mice, 
hamsters, rabbits, cattle, horses, pigs, goats, cats, monkeys, and sheep in immunodeficient 
recipient mice [6-15]. Complete spermatogenesis with generation of sperm has been 
reported in immature donor mice, hamsters, cats, rabbits, pigs, goats, cattle or rhesus 
monkeys [6-10, 16]. Fertility competence of sperm derived from testis tissue xenografts 
has been verified by the generation of blastocysts in the pig and monkey and also 
offspring in the mouse and rabbit using intracytoplasmic sperm injection (ICSI) [8, 12, 
16]. It has been speculated that higher survival rates of immature testis tissue stems from 
its superior ability to tolerate hypoxia and the more rapid establishment of vascularization 
[12, 28, 103]. Hence, as discussed in Chapter 3, this study shows the successful use of 
immature testis tissue in xenografting in a new donor species. Immature and young dogs 
were identified as the most promising donor age groups to achieve high graft survival, 
growth and development. Four months post-grafting, immature and young donor 
xenografts had markedly higher graft recovery rate, graft weight, vesicular gland index, 
seminiferous tubule number, and seminiferous tubule diameter than adult donors. 
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Immature donors showed higher graft weight, vesicular gland index, seminiferous tubule 
number and tubular diameter than adult donors eight months after grafting, as well. 
However, young donors showed variable graft recovery rates, growth and development, 
along with quantitatively and qualitatively less efficient spermatogenesis (Fig. 3.2, 3.3, 
3.4E, F). Lower efficiency of spermatogenesis might be due to initial germ cells loss and 
subsequent developmental dysfunction in testis tissues after xenografting [15]. Grafts from 
adult donors revealed degeneration with partial maintenance or recovery of 
spermatogenesis. Although partial recovery of very few seminiferous tubules is 
significant, other reports have also demonstrated degenerative changes as the major 
outcome in xenografting of adult hamsters, horses, cats, and humans [7, 11, 49, 60]. 
Therefore, mature testis donors might not be well suited for testis tissue xenografting. 
Indeed, building on this successful study could be helpful to demonstrate fertility 
competence of graft-originated sperm by generating embryos from these immature testis 
donors, a task which was beyond the scope of this MSc project. Fertility competence of 
xenogeneic sperm and production of new progeny are the final goals of this approach in 
various species. Assessment of fertility competence of dog xenogeneic sperm is the next 
step in canine testis tissue xenografting. Broad applicability of testis tissue xenografting 
could offer new experimental and practical methods which could be applied in domestic 
and nondomestic canids. 
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It is not always possible, however, to xenograft the testis tissue immediately; hence, we 
needed to preserve the testis tissue in a protected status to conserve the fertility potential. 
Salvaging genetic potential through cryopreservation of testis tissue has great clinical 
significance in preservation and restoration of fertility in animals and humans. This could 
be highly beneficial where testis tissue is the only source of potential gametes for some 
immature rare or threatened species. Other approaches such as semen freezing are not 
applicable to immature testis tissue where sperm production is not yet manifested. 
Cryopreservation will greatly expand the feasibility of testis tissue xenografting and add to 
its versatility as a powerful tool in experimental and clinical restoration of fertility.  
The porcine model was chosen since it provided consistent and continuous supplies of 
testis tissue, available through the local university affiliated swine facility. We 
investigated two cryopreservation conditions for immature porcine testis tissue. 
Cryopreservation using precisely controlled conditions via automated programmed slow 
freezing, and by ultrafast-freezing using vitrification methods were studied. Programmed 
slow freezing with glycerol-based solutions led to high in vitro cell survival and 
restoration of in vivo developmental potential. With respect to slow-freezing, 
cryopreservation of testis tissue with glycerol showed higher (~88%) post-thaw cell 
survival than with DMSO or ethylene glycol. This cell viability was comparable to cooled 
or even fresh tissues. This finding is in contrast to a recent report by Milazzo et al. (2008) 
showing higher cell viability (~90%) with programmed slow-freezing of immature mouse 
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testis tissue using DMSO as a cryoprotectant [122]. Keros et al. (2005) have also shown 
detrimental effects of glycerol on testis tissue of human adult patients [115]. However, our 
finding demonstrated spermatogenesis with generation of elongated spermatids after testis 
tissue xenografting into immunodeficient recipient mice. Furthermore, testis tissue 
vitrification was investigated and verified to be an extremely efficient cryopreservation 
method. We accomplished this task with testis tissue vitrification using DMSO (5-min 
exposure time) and glycerol (5 and 15 min exposure times). Successful in vitro cell 
survival along with in vivo developmental potential up to the production of elongated 
spermatids illustrated the improved conditions of ultrafast testis tissue cryopreservation. 
The results of vitrification studies are particularly important as this method is feasible in 
less elaborate laboratories or even under field conditions. To the best of our knowledge, 
this is one of the first reports of testis tissue vitrification and xenografting into recipient 
mice. Vitrified tissues successfully exhibited complete spermatogenesis after xenografting.  
It is intuitively known that optimal cryopreservation requires refinement of the freezing 
and thawing rates, osmotic conditions, choice and concentration of cryoprotectants, and 
equilibration times in cryoprotective solutions [81, 82, 86, 133]. Indeed, improvement of 
all aspects of freezing techniques will ensure survival rates of tissue structure and 
subsequent functional restoration of cryopreserved cells within those tissues. Testis tissue 
cryopreservation could offer a unique approach in preservation of gonadal germ cells or 
tissues for valuable experimental animals, as well as, rare or endangered species that die 
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prematurely. Although ethical and technical issues have yet to be addressed, gonadal cell 
or tissue cryopreservation might also serve as a novel alternative for preservation of 
fertility in prepubertal boys undergoing gonadotoxic cancer treatments. Moreover, 
functional restoration of gonadal cells and tissues via cryopreservation could offer an 
experimental platform for further evaluation of reproductive cell and tissue potential after 
long-term storage.  
Our studies also revealed that short-term storage of intact testis tissue at 4 °C up to 72 hr is 
a practical option which would enable the shipment of testis tissue. Short-term storage of 
tissue at 4 °C maintained the cell viability, in vivo growth, and tissue developmental 
potential with complete spermatogenesis after grafting. These results are comparable to 
those of fresh tissue xenografts. This finding is in agreement with the previous report on 
successful xenografting of 48 hr refrigerated testis tissue [6]. Our results generally concur 
with an earlier study in which non-human primate testis tissues were cooled for 24 hrs 
prior to grafting, then analyzed at 4 months post-grafting [120]. However, our results show 
a far higher graft survival rate and a 10-30 fold greater graft weight at four months post-
grafting. 
Based on these studies, conclusions can be summarized as follows: After xenografting, 
development of immature donor dog testis tissue and establishment of spermatogenesis 
can be achieved. Cryopreservation is a feasible method which enhances the relevance of 
testis tissue xenografting when immediate grafting is not applicable or desired. Automated 
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slow freezing with glycerol and vitrification of testis tissue are both suitable approaches 
for successful testis tissue cryopreservation enabling tissue survival and developmental 
potential. These findings advance the knowledge for the preservation of male fertility 
using either an automated programmable freezer or a simple vitrification procedure. 
Moreover, in vitro viability assessment of testis tissues after enzymatic digestion could 
serve as a fast and highly predictive approach for evaluating different 
cooling/cryopreservation protocols. 
Overall, these results are pertinent to wide-ranging applications of tissue in vitro 
preservation and in vivo restoration. These techniques could be considered as important 
steps to develop feasible approaches for gonadal tissue preservation which could be 
applicable in human and animal clinical settings. Current findings certainly suggest that 
age-related differences exist and impact on the success of dog testis tissue xenografting. 
There is also a need for additional studies to determine the fertility competence of 
xenogeneic sperm or elongated spermatids. Our findings in short-term and long-term 
preservation of testis tissue are applicable for clinical and experimental purposes. 
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CHAPTER 6: RELEVANCE AND FUTURE APPLICATIONS 
6.1 Relevance of this research 
These results could have profound impacts on further studies aimed at both in vitro and in 
vivo gonadal tissue preservation in animals. This research also provides applicable 
protocols for in vitro preservation and / or cryopreservation of testis tissue for future 
applications. 
6.1.1 Applications in animal conservation  
Many wild life species are protected by laws to save them from extinction. Wild life law 
enforcement, sustainable economic procedures, environmental education and prevention 
of illegal wild life trade have all been partially successful in dealing with the crisis in 
habitat protection and wild life conservation.  Research is increasingly recognized as one 
means to improve the understanding of risk factors and to seek the best solutions for 
wild life preservation. Gonadal cell and tissue preservation is an important addition to 
other assisted reproductive technologies to sustain endangered species.  Short-term testis 
tissue maintenance and cryopreservation offer a possible alternative in rescuing genetic 
resources from, exceedingly rare or endangered male species that die prematurely. 
In our studies, we developed the conditions for cryopreservation of testis tissue in order 
to be able to maintain the structural integrity and developmental potential (Chapter 4). 
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Future studies could seek to expand these methods of testis tissue cryopreservation to a 
variety of different species. 
6.1.2 Future applications in human infertility issues  
Germ cells undergoing rapid self-renewal and differentiation are especially at risk of 
cytotoxic damage after exposure to oncological therapies [124]. Infertility concerns for 
certain patients, particularly prepubertal boys undergoing cancer therapies or suffering 
from genetic defects, are a further reason to continue the study of cryopreservation and 
xenografting. However, the advances in scientific technology and experimental 
approaches can not overlook the ethical issues surrounding the risk of disease 
transmissions and inherent nature of a specific technique and its context.  
Testis tissue has the potential to restore fertility with a reduced risk of re-introduction and 
transmission of oncogenic cells [6, 60]. Grafting of fresh or cryopreserved testis tissue 
provides a method to study and manipulate primate spermatogenesis and steroidogenesis 
in a laboratory model, as it is not feasible in humans in situ [6]. 
6.1.3 Experimental applications 
Successful establishment of spermatogenesis with generation of elongated spermatids in 
dog donor testis tissue xenografts in recipient mice further confirms that testis tissue 
xenografting could serve as a model to study dog testis function in a laboratory model.  
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Xenografting might also facilitate gamete production from transgenic lines for biomedical 
research. Additionally, these methods could offer new approaches to preserve the neonatal 
lethal transgenic, mutant or cloned animals for experimental purposes [6].  
6.2 Areas of future research on extra-corporeal preservation of testis tissue  
This study proved the feasibility of growth and development of fresh and cryopreserved 
testis tissue after xenografting into recipient mice. Although there are serious technical and 
ethical problems involved in the application of these methods, there are other research 
applications for xenografting. 
 The effect of different cytotoxic drugs on human testis tissue must be examined to 
determine their selective influence on specific spermatogenic cells [120]. This could be 
achieved using testis tissue xenografts as a model. Particularly, it would be an important 
tool in exploring approaches for avoiding the irreversible damages of these drugs in cancer 
patients undergoing gonadotoxic oncological treatments. 
 Finding exclusive markers for particular stages of spermatogenic cells could be 
beneficial in cases where functional evaluation of spermatogenesis is required for future 
clinical practice. 
 Problems such as low success rate and high mortality of cloned offsprings after 
nuclear transfer can be avoided by grafting [61]. In fact, cloning does not provide genetic 
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diversity in a way that is provided by millions of genetically unique sperm produced in a 
graft. Therefore, practical improvements in xenografting of testis tissue from experimental 
animals can offer the possibility of germ cell development and gametogenesis from 
resourceless animals such as cloned, neonatally lethal, mutant, transgenic or knock-out 
animals. 
 Study and manipulation of spermatogenesis and steroidogenesis could be facilitated 
using improved cryopreservation conditions and xenografting techniques offered in our 
study. Since spermatogenesis is an extremely organized process, even slight changes could 
be intrusive for the system. However, applying such manipulations in large animals, wild 
life, and humans is considerably easier in a laboratory environment. 
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